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Abstract
Cardiovascular disease is the leading cause of death in the western 
world. Hypertension is a major risk factor for cardiovascular 
diseases and blood pressure is in turn markedly influenced by large 
artery stiffness. Recently a number of studies have reported that 
apparently healthy normotensive individuals who exhibit an 
exaggerated systolic blood pressure response on exercise are at 
increased risk of developing subsequent sustained hypertension and 
cardiovascular disease. It  is likely that an exaggerated systolic 
blood pressure response on exercise represents an abnormal 
response of the large artery during dynamic exercise. In this thesis 
the normal responses of large arteries to different types and 
intensities of exercise was investigated in healthy normotensive 
subjects. Whilst distensibility of limb conduit arteries was measured 
for up to 15 minutes following exercise aortic distensibility did not 
change. An exaggerated systolic blood pressure response on 
exercise was not observed in healthy subjects without other 
conventional cardiovascular risk factors, but was observed 
frequently in the presence of such risk factors. Subjects with an 
exaggerated systolic blood pressure response on exercise did not 
show increased limb conduit artery distensibility immediately 
following exercise (and by implication during exercise). Blockade of 
NO synthesis prevented the increase in limb conduit artery
11
distensibility seen in the first few minutes following exercise, but did 
not abrogate the more sustained increase in arterial distensibility 
following exercise. Systemic blockade of NO synthesis caused 
marked changes in systemic haemodynamics at risk, but these were 
markedly attenuated during exercise. The impact of mental stress 
on arterial function was also assessed. Whilst peripheral 
microvessels vasodilated, large arteries stiffened and this largely 
accounted for the observed increase in blood pressure.
12
Chapter One
Introduction
H eart Disease in the United Kingdom
Diseases of the heart and circulatory system (CVD) are the number 
one causes of death in the United Kingdom (UK), with over 240,000 
deaths in 20011,2 (Table 1.1). Forty percent of all deaths in the UK 
are from CVD. CVD is made up of coronary heart disease (CHD) 
and stroke, with a 3:1 ratio of CHD to stroke. The cost of treatment 
of CVD is about £1.75 billion per annum. This is split between 
hospital care (53% ), drug administration (34% ), and 12% on other 
expenses. If  the economic cost of days lost to illness, death and 
informal care of patients is included the total rises to just over 
seven billion pounds per year1,2. Less than one percent is spent on 
research into the primary prevention of CVD.
Blood Pressure and Cardiovascular Risk
Blood pressure is a significant risk factor for cardiovascular disease 
and the characteristics of the large arteries play a significant role in 
determining blood pressure3. Blood pressure is made up of two 
components, the systolic blood pressure (SBP) and the diastolic 
blood pressure (DBP). The SBP reflects the pressure exerted on the 
arterial wall as the ventricle ejects or is in contraction. The DBP is a 
measure of the pressure exerted on the arterial wall when the 
ventricle is filling or in relaxation. The guidelines from the American 
Heart Association (AHA), the World Health Organisation (WHO) and 
the British Heart Foundation (BHF) are that resting blood pressure
14
should be less than or equal to 120 over 80 (mmHg) and that 
hypertension is defined as a blood pressure in excess of 140 over 
90 (mmHg)4,5.
Table 1.1 Deaths by cause, sex and age, 2001 , United  
Kingdom
Cause Sex All
Ages
< 35 35-44 45-54 55-64 65-74 75 +
All causes M 287,062 9,940 7,193 15,542 32,000 66,063 156,324
F 315,960 5,179 4,453 10,310 20,402 47,027 228,589
Total 603,022 15,119 11,646 25,852 52,402 113,090 384,913
All M 114,336 549 1,508 5,115 11,882 27,732 67,910
circulatory F 125,931 291 675 1,783 4,849 16,398 101,935
diseases Total 240,267 840 2,183 6,898 16,731 43,770 169,845
Coronary M 66,400 122 885 3,581 8,358 17,579 35,875
Heart F 54,491 26 195 758 2,514 8,642 42,356
Disease Total 120,891 148 1080 4,339 10,872 26,221 78,231
Stroke M 25,208 118 249 675 1,588 4,724 17,854
F 41,518 86 244 573 1,179 4,091 35,345
Total 66,726 204 493 1,248 2,767 8,815 53,199
Diabetes M 3,350 39 86 171 373 900 1,781
F 3,628 29 44 69 219 650 2,617
Total 6,978 68 130 240 592 1,550 4,398
Cancer M 81,992 821 1,247 4,872 12,685 24,043 38,324
F 76,531 805 1,852 5,354 10,487 18,533 39,500
Total 158,523 1,626 3,099 10,226 23,172 42,576 77,824
Colo-rectal M 8,528 19 112 528 1,368 2,582 3,919
cancer F 7,627 28 96 331 812 1,625 4,735
Total 16,155 47 208 859 2,180 4,207 8,654
Lung M 20,437 18 136 1,087 3,490 6,953 8,753
cancer F 13,027 11 119 822 1,991 4,183 5,946
Total 33,509 29 255 1,909 5,481 11,136 14,699
Breast F 13,011 123 703 1,615 2,258 2,650 5,662
cancer Total 13,011 123 703 1,615 2,258 2,650 5,662
Respiratory M 34,848 249 271 722 2,246 6,702 24,658
Disease F 40,961 203 189 559 1,574 5,154 33,282
Total 75,809 452 460 1,281 3,820 11,856 57,940
Injuries M 12,540 4,163 2,123 1,650 1,192 1,048 2,364
and F 7,580 1,075 648 603 514 667 4,073
poisoning Total 20,120 5,238 2,771 2,253 1,706 1,715 6,437
All other M 39,996 4,119 1,958 3,012 3,622 5,998 21,287
causes F 61,329 2,776 1,045 1,942 2,759 5,625 47,182
Total 101,325 6,895 3,003 4,954 6,381 11,623 68,469
Office for National Statistics (2002) Deaths registered in England 2001 by cause and area of residence, personal 
communication.
Office for National Statistics (2002) Deaths registered in Wales 2001 by cause and area of residence, personal 
communication.
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The significance of raised blood pressure as a leading risk factor for 
CVD was highlighted in the recent WHO report3. Hypertension or 
raised blood pressure was identified as the second most influential 
risk factor for mortality and morbidity, exceeded only by tobacco. 
Within the UK about 50% of men and women aged between 65 and 
74 are hypertensives or are receiving treatment for raised blood 
pressure. Approximately 80% of these patients are not receiving 
treatment (32% of this older population). Of note is that of those 
who are treated, 60% continue to be hypertensive despite therapy. 
Population based studies have consistently demonstrated that a 
continuous and positive relationship exists between blood pressure 
and mortality. However, studies examining the effects of 
pharmacological hypertensive treatments have shown a U-shaped 
relationship with an increased risk of events for subjects with low 
blood pressure6. The Framingham study into the effects of blood 
pressure on cardiovascular disease is the most cited piece of 
literature in this field7, it has several updated publications and as a 
summary has concluded that of the three most related measures of 
blood pressure and mortality are SBP, DBP and Pulse Pressure (PP)8, 
9. However, when analysed for age and blood pressure there is a 
difference in the predictive value of each measure (Table 1.2)8. The 
younger population of the Framingham study (<50 years old) show 
a significantly stronger predictive value for DBP than either SBP or 
PP (but all were prognostic), while all three pressures have similar
16
predictive values in the middle age group (50 -5 9  years old). In 
the older group (>60 years old) the strongest relationship was with 
PP, then SBP, with little or no value in adding DBP to the risk 
profile8. This led the authors to postulate that the under 50 group 
must have an abnormal systemic vascular resistance, whereas in 
older subjects the primary abnormality is one of large artery 
stiffness which fits with previous pathophysiological studies10'13. 
This also fits with the cardiovascular disease profile of the old with a 
high incidence of isolated systolic hypertensive with a wide pulse 
pressure. There have been similar findings in other large 
epidemiological trials14,15.
Table 1.2 Proportional-Hazard Regression Coefficients 
Relating Incidence of CHD to  single BP Components o f SBP, 
DBP, and PP by Age Groups8' 10
Single BP 
Components
B+ SEt W ald
x 2 t
HR (9 5 %  C I)+
<50 years
SBP 0.13 0.04 10.8 1.14 (1.06-1.24)!
DBP 0.29 0.06 21.8 1.34 (1.18-1.51)11
PP 0.02 0.07 0.1 1.02 (0 .89-1 .17)
50-60 years
SBP 0.08 0.03 6.3 1.08 (1 .0 2 -1 .15)§
DBP 0.10 0.06 2.9 1.11 (0 .99-1.24)
PP 0.11 0.05 5.4 1.11 (1 .02-1.22)§
>60 years
SBP 0.16 0.03 30.0 1.17 (1.11-1.24)11
DBP 0.11 0.06 3.2 1.12 (0 .99-1 .27)
PP 0.21 0.04 36.9 1.24 (1.16-1.33)11
*SBP, DBP, and PP were entered in separate models, adjusted for age, sex, body mass index, 
cigarette smoking, diabetes mellitus, and ratio of total to HDL cholesterol. §=P<0.05, !=P<0.01, 
H=P<0.001.
17
Blood Pressure control
Blood pressure is controlled on both an acute and chronic basis. 
Acute changes occur with each beat of the heart, with inspiration 
and expiration and in response to changes in orthostatic position or 
other physiological stresses. Both chronic and acute changes share 
similar mechanisms to alter and control the pressure. The main 
acute and chronic mechanisms involved on the short and long-term 
control of blood pressure are highlighted below. The arterial 
Baroreceptor reflex is the single most important mechanism 
providing acute modulation of arterial pressure. As is usual in a 
reflex pathway there are sensory receptors, afferent and efferent 
pathways, integration with the central nervous system (CNS) and 
effector organs16. We include a simplified diagram to show the link 
between each of the stages of the pathway that we will discuss 
below (Fig 1.1).
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Figure 1.1 Mechanisms of blood pressure control schematic  
Decrease Mean A rteria l Pressure
I
- in baroreceptor discharge
I
Medullary Cardiovascular Centres
+ sympathetic activityv - parasympathetic activity
+ blood volume
+ peripheral venous pressure
transcapillary fluid reabsorption
central venous pressure
-capillary pressure
+ vasoconstriction + stroke volume
+ heart rate
/
+ cardiac output+ total peripheral resistance
Increase mean arteria l pressure
Note: - = decrease and +  = increase
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The afferent pathways are made up of sensory receptors commonly 
called the arterial baroreceptors. These receptors are found in the 
walls of the aorta, coronary and carotid arteries. The receptors 
themselves are mechanoreceptors that judge the degree of 
pressure from the degree of arterial stretch. Under normal 
conditions an increase in stretch causes an increased rate of firing 
of the baroreceptors. Baroreceptors are affected by both the mean 
arterial pressure but also by the arterial pulse pressure as they 
respond to both the change in pressure and the rate of change in 
pressure. The greatest changes in the rate of baroreceptor nerve 
activity occur between mean blood pressures of 90 and 110 mmHg, 
this demonstrates a marked ability to return the pressure to its 
normal values of around 95 mmHg. If  arterial pressure remains 
elevated for a period of days the arterial baroreflex activity will 
return to normal levels (i.e. they adapt to a higher set point), thus 
arterial baroreceptors play no role in the chronic changes in arterial 
pressure. The medullary cardiovascular centre within the brain is 
where central integration occurs. The exact role and locations of 
each centre is not specifically known or wholly mapped out and is 
not of great significance to this review. We will therefore give an 
outline of their role in the responses to arterial pressure changes. 
The major external influence comes from arterial baroreceptors; 
this influence is continuous as baroreceptors are active at normal 
pressures. An increased input from the baroreceptors results in
20
inhibition of the spinal sympathetic outflow with concurrent 
stimulation of the parasympathetic inhibitory tract and 
preganglionic nerves. This leads to a reduction in sympathetic and 
an increase in parasympathetic nerve activity. If arterial pressure 
falls, the opposite response causes a decrease in parasympathetic 
activity and an increase in sympathetic activity.
The efferent pathways are the sympathetic and parasympathetic 
nerves that lead to the heart and blood vessels. These nerves 
contain preganglionic and postganglionic fibres, which are outside 
the CNS and form the terminal link to the heart and vessels16. 
Other reflexes and receptors influencing blood pressure including 
the dive reflex, pain reflex and the so called "low pressure" 
receptors and chemoreceptors in the heart and lung receptors. 
These reflexes cause large and rapid alterations in arterial blood 
pressure, which are short term and are therefore not relevant to 
this review16. We outline below the cardiovascular changes that 
occur following a drop in mean arterial blood pressure (Fig 1.1).
Arterial Blood pressure
As the left ventricle contracts there is a rapid rise in ventricular 
pressure until the left ventricular pressure exceeds the aortic 
pressure and the aortic valve opens, the pressure in the ventricles 
then rises at a steady rate as the blood is ejected into the aorta.
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The blood in the aorta causes the walls of the artery to stretch and 
therefore the pressure rises. As the ventricular pressure falls and 
the flow of blood from the ventricle falls there is maintenance of 
arterial pressure due to the elastic recoil of the arteries. On closure 
of the aortic valve the pressure in the aorta falls slowly (Diastole) as 
the blood flows continually through the peripheral vessels and back 
to the veins.
As briefly described above there are two elements that maintain this 
arterial pressure, the elasticity of the arteries and the downstream 
resistance vessels. If  either of these physiological mechanisms 
were not present the arterial pressure trace would mirror that of the 
ventricular pressure volume curve. These two elements have been 
described as the pulsatile and static components or arterial blood 
pressure. The static component is frequently measured as systemic 
vascular resistance, defined as the mean blood pressure (Diastolic 
BP plus 1/3 of the Pulse Pressure) divided by the cardiac output and 
at rest ranges from 16 -  24 mmHg/L. The pulsatile component or 
pulse pressure is affected by three factors, firstly the actual stroke 
volume, secondly the arterial compliance (or distensibility) and 
thirdly the character of ejection from the heart during systole. In 
general the greater the stroke volume, the greater the pulsatile 
component, while the opposite is true of compliance. We will 
discuss further the interaction between the ventricles and the large
22
arteries at the end of this chapter and the measurements we use to 
access arterial compliance is covered in chapter 2. Arterial 
elastance can be measured using the ratio of end systolic pressure 
to stroke volume and is a measure of the combined effects of 
pulsatile and static afterload/elastance, but is also influenced by 
heart rate.
Cardiovascular Responses to  Exercise
At rest, cardiac output (CO) is approximately 5 (L/min) with a mean 
blood pressure of 90 (mmHg) resulting in a calculated systemic 
vascular resistance (SVR) of 18 (mmHg/L). On exercise, CO 
increases to meet the increased energy demand of the locomotor 
muscles. CO is increased by two mechanisms; the first is by an 
increase in heart rate (HR) that will generally increase up to a 
maximal heart rate of 220 minus age in years17. The initial increase 
in HR is due to parasympathetic withdrawal, up until a HR of 100 
and then the continued increase is due to sympathetic activation18, 
19. The second mechanism to increase CO is an increase in stroke 
volume (SV), which will generally increase during exercise up until a 
HR of 120-14020. The SV rises because of an increase in the end 
diastolic volume (via the frank-Starling mechanism) as a result of a 
translation of blood from the venous component to the heart as a 
result of venoconstriction, and also because of a small increase in 
ejection fraction20.
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A healthy untrained, 20 year old male will generally be able to 
generate a C O max of 20 (L/min) that is made up of a HR of 200 
(bts/min) and a SV of 100 (ml). If  SVR had maintained its basal 
tone (18 mmHg/L), the net result would be a mean blood pressure 
of 360 (mmHg) at peak exercise (20(1)* 18 (mmHg/L)). In fact 
SVR falls during exercise and at maximal exercise is about 6 
(mmHg/L) resulting in a MBP of approximately 120 (mmHg)18,19,21. 
Figure 1.2 demonstrates the graded response in cardiovascular 
variables from rest to maximal exercise. As depicted, Systemic 
Vascular Resistance falls by almost three-fold from baseline to peak 
exercise. This, however, is the composite of two very different 
responses in exercising versus non-exercising vascular beds. The 
exercising beds demonstrate profound vasodilation, so much so that 
the limb blood flow can increase 2000% from baseline18, 22. This is 
believed to be through a series of local metabolic factors, which 
include adenosine, augmented by shear-related nitric oxide release. 
There is marked vasoconstriction in the non-exercising regions 
(forearm, kidneys and intestine). This is due to a complex 
interaction of opposing vasoconstrictor and vasodilator neural, and 
neurohumoral influences. The "central command reflex" and input 
from skeletal muscle ergoreceptors and metaboreceptors both 
promote sympathetic outflow from the brainstem (vasoconstriction). 
As exercise duration and/or intensity increases plasma arginine
24
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vasopressin, angiotensin I I  and endothelin rise substantially and 
contribute to increased vasoconstriction of the non-exercising 
regions. These constrictor influences may be attenuated by neural 
input from arterial baroreceptors and from mechanoreceptors in the 
atria and left ventricle, in response to the rise in arterial stretch18,
22-24
Figure 1.2 Cardiovascular Responses to Execise18'
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Exaggerated Systolic Blood Pressure Response to Exercise
In 1991 Faggard et al showed that in a hypertensive group of men 
(n=143) who had been assessed for resting and exercise blood 
pressure between 1972 and 1982, that exercise blood pressure was 
a significant predictor of mortality and CV events. However when 
resting blood pressure and age were added to the analysis the 
exercise blood pressure carried no additional effect25. In contrast, 
Filipovsky et al showed that an exaggerated systolic blood pressure 
response to exercise (ExSBP) was of prognostic significance in 
middle-aged men, independent of resting blood pressure. They 
studied 4,907 men over a 17-year period and independent of other 
risk factors the rise in blood pressure from rest to peak exercise 
was positively associated with cardiac and all cause m ortality26. 
Using Cox regression analysis they demonstrated that systolic blood 
pressure after five minutes of cycling and the increase in systolic
26
pressure (Exercising -  Resting) was significantly associated with 
cardiovascular mortality. Of note is that they found no relationship 
between resting systolic pressure or exercise heart rate and 
mortality. 2-years later, Mundal et al reported a study of 1,999 
men followed up over a 16-year period, the exercise blood pressure 
was measured as the systolic pressure after 6 minutes of cycling at 
100-Watts27. They demonstrated that when casual blood pressure 
and ExSBP were analysed simultaneously as continuous variables 
the independent predictive value of the casual BP became non­
significant. The same group later published a further follow up to 
this study and demonstrated that in subjects with a moderate 
increase in resting blood pressure (140 mmHg) that those with a 
more marked increase in ExSBP (>200 mmHg) were at a 
significantly greater risk for myocardial infarction than those with a 
the same moderate rise in resting BP but an ExSBP < 200 
(mmHg)28. The most recent papers from this same study group 
were in 1997 and 2001 and included the 21 year follow up results, 
this demonstrated that only supine and 6 minute exercise blood 
pressure were independently predictive of cardiovascular events29,
30
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The ExSBP in subjects with a high-normal BP can be used to predict 
future essential hypertension as Miyai et al showed in 239 men over 
a 5 year follow up31. Kurl and colleagues looked at the rate of blood 
pressure increase and the risk of stroke during upright cycle 
ergometry (20 watt increase per minute) and found that those men 
with an increase in ExSBP of greater than 19.7 mmHg per minute 
had a 2.3 fold increased risk of stroke and also a 2.3 risk of 
ischemic stroke when compared to the men whose SBP rise was less 
than 16.1 mmHg per minute32. Blood pressure following exercise in 
6557 normotensive (<  130/85) and borderline hypertensives 
Japanese (130-140 /  85-90 mmHg) was shown to confer a relative 
risk of developing hypertension of 1.55 per 10 mmHg increase in 
post exercise SBP and DBP33. These associations were independent 
of resting BP. Even after stratifying subjects according to blood 
pressure at rest, SBP or DBP 4 minutes post exercise was 
associated with an increased risk of long-term development of 
hypertension. The exercise performed, is called the "Two-step" 
exercise test, and involves walking up two steps, each 23 
centimetres high and then going down the other side. The number 
of trips undertaken is dependent on age and weight. To determine 
the prognostic significance of an ExSBP (>60 mmHg SBP rise at 5 
min, or >70 SBP mmHg at 10 min, or >10 mmHg in DBP a any 
time) and the risk of future hypertension in normotensive men, 
Matthews and colleagues reviewed 5386 treadmill tests carried out
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over a twelve year period and showed that those who had an ExSBP 
had an Odds Ratio of 3.0 (Cl 1.5-6.1) when sitting systolic and 
diastolic pressures, age, familial history and BMI were controlled 
for34. In subjects (n=239) with an already high-normal BP (135/86) 
Miyai et al demonstrated that those with the greatest increase in 
ExSBP had a greater risk of developing hypertension, independently 
of other resting measures35. In the first controlled study Sharabi et 
al re-analysed the data from a three-year period of male subjects 
whom had completed an exercise stress test with BP readings. 
They defined an ExSBP as an excess of 200 (mmHg) and an ExDBP 
being in excess of 100 (mmHg) at peak exercise. From this data 
they identified 73 subjects with an ExSBP and matched them with 
117 controls. Over the follow up period 22% of subjects with an 
ExSBP developed hypertension compared to just 2.6% of the 
control group (P<0.05)36.
All of the tests used to predict future events or hypertension have 
one common flaw and that is they use a standard workload that is 
independent of fitness levels. As we demonstrated earlier blood 
pressure and exercise intensity are linearly related and therefore 
the higher the increase in intensity the higher the ExSBP. Miyai et 
al addressed this by analysing 1033 normotensive males SBP and 
DBP during sub-maximal exercise at different heart rates31. Even 
after taking into account the exercise intensity, they still
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demonstrated a 3.8 fold relative risk with an ExSBP above the 90th 
percentile.
We are only aware of one study to date that has failed to show a 
link between ExSBP and risk/prognosis, this was carried out in a 
highly trained (V o 2max 59.4, ml/kg/min) group and a sedentary 
control group (44.7 ml/kg/min). They used the peak blood pressure 
of each individual for analysis and showed no prognostic value. It  is 
important then to understand that subjects with athletic training 
can exercise to higher levels of exertion at higher cardiac outputs 
and for a greater duration, all of which can lead to a significant rise 
in ExSBP, hence making this result questionable.
In summary ExSBP not only predicts which normotensive and 
borderline hypertensive subjects will become hypertensive it also 
can be used as a tool to predict cardiovascular death from 
myocardial infarction and stroke, independent of resting blood 
pressure
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Table 1.3 Summary of Exercise Blood Pressure and 
Cardiovascular Disease
Author 
and Year
Sub
(n)
Blood Pressure 
Studied
Outcome Measure
Faggard
1991
143 5th minute of 
exercise
Positive Relationship 
between ExSBP and CV 
Mortality
Filipovsky
1992
4907 Delta Rest to Peak 
Exercise SBP
Positive Relationship 
between ExSBP and CV 
Mortality
Mudal
1994
1999 6 minute SBP at 100 
Watts (Cycling)
Positive Relationship 
between ExSBP and 
Myocardial Infarction
Kjelsden
1997
1999 6 minute SBP at 100 
Watts (Cycling)
Positive Relationship 
between ExSBP and 
Myocardial Infarction, Stroke 
and Hypertension
Kjelsden
2001
1999 6 minute SBP at 100 
Watts (Cycling)
Positive Relationship 
between ExSBP and 
Myocardial Infarction, Stroke 
and Hypertension
Miyai
2002
239 Submaximal Blood 
Pressures
Positive Relationship 
between ExSBP and 
Hypertension
Kurl
2001
1026 Change in SBP of 
19.7 mmHg V 16.1 
mmHg per stage
Positive Relationship 
between ExSBP and Stroke
Tsumura
2002
6557 1.55 increased risk 
for every 10 mmHg 
change in BP
Positive Relationship 
between ExSBP and 
Hypertension
Matthews
1998
5386 >60mmHg - 5 min 
>70mmHg - 10 min 
>10mmHg -  DBP
Positive Relationship 
between ExSBP and 
Hypertension
Sharabi
2001
190 SBP>200
DBP>100
Positive Relationship 
between ExSBP and 
Hypertension
Miyai
2000
1033 Submaximal Blood 
Pressures
Positive Relationship 
between ExSBP and 
Hypertension
Sharabi
2001
76 Maximal SBP No Relationships
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Large A rtery Properties and Blood Pressure
Large artery function plays a significant role in determining pulse, 
systolic and exercise blood pressure and as such will play a 
prominent role in our understanding of the ExSBP. In fact recent 
work has shown that arterial stiffness per se is an independent 
marker of risk37"41. The increase in large artery, particularly aortic, 
stiffness is of profound importance to the occurrence of increased 
PP with age and disease status. The consequences of this stiffness 
lead to both reduced arterial compliance and increased PWV. 
Reduced compliance will increase PP due to a reduced "buffering" 
capacity available from the arterial wall, while an increase in PWV 
will increase systolic pressure augmentation. These important 
consequences can be understood further with the analysis of the 
pulse pressure waveform. Before we continue with the assessment 
of large artery stiffness it is important to understand the basic 
anatomy and physiology of the arteries.
The overall function of the arterial system is to distribute blood from 
the heart to the peripheral arteries as efficiently as possible, with 
minimal mean pressure drop from input to termination, and with 
minimal pressure fluctuations at the heart and minimal pulsatile 
energy losses throughout. This is usually achieved in the young and 
healthy. However, aging and various disease states progressively 
impair arterial function. Elevated pulse pressure (PP) is increasingly
32
being recognised as a risk for cardiovascular particularly coronary 
disease9,13,42. PP can be discussed in terms of the Windkessel and 
distributive models of arterial circulation. In its simplest, two 
element form, the Windkessel model describes the circulation in 
terms of parallel resistance and capacitance components. The 
resistance element corresponds to measured peripheral vascular 
resistance, while the capacitance element corresponds to the 
compliance (C) of the arterial circulation. Compliance is simply a 
measure of the capacity of a volume-containing structure, such as 
the arterial system, to accommodate further increases in volume. 
While C is widely distributed throughout the arterial tree, total 
systemic arterial C is predominantly determined by the aorta and its 
major branches. Arterial C can be estimated from the decay in 
diastolic pressure as well as by the simpler approach of: C = Stroke 
Volume (SV)/PP. It is apparent from this approximation that 
elevations of PP can be secondary to a rise in SV or a fall in C. The 
rise in PP (or systolic pressure) with age in healthy subjects relates 
to a fall in C, whereas elevation of PP in the young appears to be 
related to increases in SV and bears no clinical risk43. The value of 
the Windkessel model is limited as a comprehensive explanation of 
arterial behaviour under differing circumstances. Analysis of the 
arterial system solely using the Windkessel model is restricted since 
it assumes that ail pressure changes occur instantaneously, 
whereas the circulation serves to distribute cardiac output through a
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series of branching networks. The elastic properties described by 
the model are not present at just one site but are distributed along 
the aorta and major arteries. Therefore, the Windkessel model is 
unable to explain important phenomena such as wave reflection and 
frequency dependence44. The pressure wave has a finite wave 
velocity in arteries, and in addition, pressure waveforms are 
different in amplitude and contour in central and peripheral 
arteries45. While the advantage of the two-element Windkessel 
model is its simplicity, it fails to characterise other important 
determinants. Considering the arterial system as comprising of a 
distributed C overcomes these limitations to a large extent44.
Ejection of blood into the aorta generates a pressure wave that 
propagates to other arteries throughout the body. One of the most 
basic physiological properties of the arterial pulse is that its shape 
becomes modified as it travels along the arterial tree. The 
amplitude generally increases, and the pulse waveform features are 
altered46. Conventional measurement of cuff blood pressure fails to 
take into account these essential properties of the arterial pressure 
pulse. This means that the conventional pressure measurement, 
which gives only the maximum (systolic) and minimum (diastolic) 
values of the peripheral pressure pulse, is not an accurate measure 
of the pressure load on the heart. Pulse pressure (PP) is the 
consequence of intermittent ventricular ejection from the heart. PP
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is influenced by several cardiac and vascular factors, but it is the 
role of large conduit arteries, mainly the aorta, to minimise 
pulsatility. In addition to the pattern of left ventricular ejection, the 
determinants of PP (and SBP) are the capacity of arteries and the 
timing and intensity of wave reflections46. The capacities of arteries 
are influenced by arterial stiffness, usually expressed in the 
quantitative terms of compliance and/or distensibility44. The timing 
and intensity of wave reflections result from the summation of a 
forward wave coming from the heart and propagating at a given 
speed toward the origin of resistance vessels and a backward wave 
returning toward the heart from particular sites of reflection along 
the arterial tree.
Large Artery stiffness is an important, independent predictor of 
cardiovascular risk in subjects with hypertension37, diabetes39, end- 
stage renal disease38, 47 and older (>70 years) subjects40, 41 and in 
the most recent of these studies was a better predictor of 
cardiovascular events than brachial blood pressure48. Large artery 
stiffness is in part determined by structural components (collagen 
and elastin), and by the transmural pressure. With age comes 
disruption of the elastin load bearing structures within the arterial 
wall, with the net result of transfer of stress to collagenous tissue 
and a stiffening of the artery. Collagen cross-linking also occurs via 
glycation, large arteries are not simply structural elements
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however; they also have vascular smooth muscle cells in their wall, 
which are under endothelial control and as such can be influenced 
through various local or circulating mediators. These arteries are 
also highly innervated with sympathetic vessels, and adrenaline and 
noradrenaline have been shown to increase and decrease large 
artery tone49. Therefore arterial stiffness as such is regulated and 
modifiable by local and central stimuli. It  has also been 
demonstrated in animals (rat) that removal of the endothelium 
causes significant changes in large artery pulse wave velocity, 
demonstrating the role of the endothelium in large artery 
stiffness50.
Active Regulation of A rteria l Stiffness
Traditionally, the stiffness of a vessel was viewed as only a function 
of the structural elements of the vessel and distending (mean 
arterial) pressure. However, the large arteries also have a generous 
coat of smooth muscle, which can alter the stresses between the 
elastic and collagenous fibres of the artery wall and thus alter the 
arteries stiffness51. The muscular arteries have a large sympathetic 
innervation and because smooth muscle tone is also influenced by 
circulating and local vasoactive substances mediators, arterial 
stiffness may be actively regulated, and modified, at least in the 
short term51.
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Arterial Stiffness and Sym pathetic Nerve Activity
Gerova52 reported that sympathetic nerve activity exerts a "tonic" 
stiffening influence on the arterial walls. In man, arterial wall 
distensibility can be reduced by an increased sympathetic drive, as 
shown by the effects on the radial and carotid arteries during cold 
pressor and mental arithmetic tests53, and smoking54, i.e. 
manoeuvres that cause sympathetic activation. Failla et al. have 
shown that in man, anaesthesia of the brachial plexus, lower spinal 
chord and lumbar sympathectomy caused an increase in the 
distensibility of the radial or femoral artery respectively55. These 
observations reflect the stiffening effect exerted by neural 
influences on the vessel wall. Significantly, arterial distensibility 
changes were limited to the vessel from which sympathetic activity 
was removed. It  is important to note that these changes were not 
associated with significant reductions in BP or HR, therefore 
excluding the possibility that the results originated from a shift in 
the distensibility-pressure curve56, or a reduction in the viscoelastic 
opposition of the arterial wall to inside pressure when HR is 
increased57. The authors concluded that in man, the sympathetic 
nervous system exerts a pronounced restraint in the distensibility of 
medium and large sized arteries. This restraint is observed not only 
when its activity is increased in a short-term manner as 
demonstrated by behavioural or emotional stimuli, but also when 
the vessel is exposed to long lasting sympathetic tone. It  was also
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speculated that since increases in distensibility were observed 
within a few minutes after the withdrawal of sympathetic influences, 
that functional rather than structural mechanisms are involved. It  is 
thought that this functional mechanism may involve the tonic 
contraction of medial smooth muscle because in vitro human 
studies53 have shown that arteries have a greater elastic modulus 
when smooth muscle is contracted. It  is finally speculated that this 
smooth muscle contraction is accounted for by the direct influence 
of sympathetic medial wall innervation55. Further evidence for the 
influence of sympathetic nerve activity influencing arterial stiffening 
is provided by the recent hand transplantation studies by 
Giannattasio et al. which report that radial denervation is 
accompanied by an increased arterial distensibility58.
The Endothelium and the Role of NO in Arterial Stiffening
The systemic infusions of drugs that promote or inhibit NO release 
have been used to investigate the role of NO in regulating large 
artery stiffness. Many studies have clearly demonstrated that NO 
donors, such as GTN, reduce augmentation index (Al), a marker of 
arterial stiffness (see later), independently of any effect on BP, in 
both healthy subjects, and in those with a range of CV risk factors 
including hypertension and hypercholesterolemia59, 60. NO donors 
have also been shown to reduce other measures of large artery 
stiffness such as PWV in hypertensive individuals, but not always
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independently from changes in distending pressure61, 62. The 
contribution of basal NO to resting large artery stiffness has been 
assessed by infusions of NOS inhibitors such as L-NMMA and L- 
NAME. Wilkinson et al have shown that systemic infusion of L-NMMA 
increases Al in healthy normal volunteers59, 60. The findings of this 
study must be interpreted with caution however, since the changes 
in stiffness observed were accompanied by increases in MAP and 
reflect changes in heart rate.
More definitive evidence for the role of NO in regulating large artery 
stiffness may come from local intra-arterial infusions of L-NMMA and 
GTN. Such techniques overcome the methodological limitations of 
systemic infusions, because the drug doses used are much lower 
and, if infusion periods are relatively short, MAP and HR and 
normally unaffected51. Studies using techniques such as 
intravascular PWV measurement, using pressure or flow waveforms, 
or direct ultrasound measurements of distensibility or compliance, 
have shown that endothelium-derived NO regulates the stiffness of 
the ovine iliac artery60. Kinlay et al. also report similar findings in 
the human brachial artery when elasticity, compliance and PWV 
were observed63. Conversely GTN or Acetylcholine administrations 
reduce arterial stiffness in the muscular arteries63, 64. Together 
these studies suggest that basal, simulated, or exogenous NO acts 
to reduce arterial stiffness in humans in vivo, independently from
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any changes in BP, highlighting the importance of the vascular 
endothelium in the functional regulation of arterial stiffness.
Endothelial Derived Hyperpolarizing Factor (EDHF)
By definition, an EDHF is a substance synthesised in, and released 
from, the endothelium which hyperpolarizes vascular smooth 
muscle cells thus reducing the open probability of voltage- 
dependent Ca2+ channels so that [Ca2+]i is lowered, and relaxation 
can take place. Although it is generally assumed that EDHF opens 
Ca2+-dependent K+ (Kca) channels to hyperpolarize the smooth 
muscle cell membrane, the mechanism of action of EDHF is 
controversial as the exact type of Kca involved remains unclear and 
some evidence now suggests that the EDHF-activated KCa are 
localised on the endothelium. Moreover, the evidence suggesting 
the involvement of a Na+-K+-ATPase cannot be ignored and many of 
the EDHF's described in different arteries are able to activate this 
electrogenic pump65.
Endothelial N itric Oxide Production
The key factor controlling vascular blood flow at rest is nitric oxide. 
Furthermore NOS production increases in response to many stimuli; 
which include shear stress66 69, acetylcholine70, bradykinin71 and 
prostaglandins72. Other stimuli inhibit the release of NOS, including 
angiotensin I I  (via inhibition of bradykinin), tumour necrosis factor
40
(TNF) which inhibits NOS and increases endothelial cell apoptosis73, 
norepinephirene, endothelin74 and vasopressin75, 76. It  has been 
demonstrated that the administration of ACE inhibitors77, the 
production of prostaglandins72, bradykinin78 and L-Arginine79 all help 
to improve vascular conductance and/or exercise performance. It  is 
quite logical to assume that part of this improvement is due to the 
agonistic or antagonistic effects these substances are known to 
have on the factors effecting endothelial function.
Nitric Oxide first appeared in the scientific literature in the mid 17th 
century in the writings of J van Helmont. Its chemical properties 
were not characterised until the mid to late 18th century when J 
Priestley gave it the name "nitrous air". Finally, in 1980 the 
physiological role of NO and the endothelium was revealed80. We 
concentrate on NO and its function within the vascular system from 
this point forward.
The vascular endothelium is a barrier between the blood and the 
vascular smooth muscle; the endothelium actively partakes in the 
control of vascular tone, blood flow and the regulation of blood 
fluidity. NO is synthesised in endothelial cells and plays a critical 
role in the maintenance of vascular tone, fluidity and the anti­
adhesive properties of the endothelium. NO acts via a cyclic 
guanosine monophosphate (cGMP) mechanism to cause 
vasorelaxation, which in turn increases perfusion and therefore
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oxygen flow. At rest, low levels of NO are continuously synthesised 
and released generating a constant counter against sympathetic 
vasoconstriction. During hypoxia, shear stress or activation of 
endothelial receptors NO synthesis increases.
Shear stress is the result of the frictional force applied to the 
endothelium by blood flow though a vessel. This can increase in 
one of two ways 1) a decrease in vessel diameter (vasoconstriction) 
without a decrease in flow, 2) or as an increase in blood flow 
without an increase in vessel diameter. Shear stress has been 
shown to potentiate agonist-stimulated NO release66,68 and chronic 
shear stress (exercise training) up regulates type I I I  NOS 
expression81, 82. Unlike the other forms of NOS, type I I I  NOS is 
membrane bound, this positioning of type I I I  NOS appears to 
enable NO synthesis to be regulated by shear stress.
There are three main isoforms of NOS of these nNOS and eNOS are 
constitutively expressed and are found in skeletal muscle. The 
effects of NO on skeletal muscle perfusion are the most significant. 
Perfusion depends on the calibre of the resistance vessels and the 
perfusion pressure applied. These are in the main mediated by 
neural and metabolic effects with small but significant changes also 
coming from the endothelium and the muscle pump. Therefore the 
main determinant of resistance vessel calibre is the ongoing
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vasodilatory effects (Hydrogen, Oxygen pressure, Carbon Dioxide 
Pressure, Adenosine, Magnesium and Potassium) balanced against 
the sympathetic activation from metabolite and mechanical 
receptors in the muscle.
Indices of Arterial Stiffness
O'Rourke et al highlighted a number of reservations in the 
measurement and interpretation of many of the indices used to 
calculate arterial stiffness45. These common misgivings include the 
use of an inappropriate arterial model (e.g. Windkessel), and 
problems when changes in proximal arterial diameter are related to 
pressure changes at a distant site. Arterial stiffness cannot be fully 
understood without examining the factors that control and regulate 
it.
A rterial Stiffness Measurem ent
Many methodologies, both invasive and non-invasive, have been 
applied to the assessment of arterial elasticity in vivo. Non-invasive 
measures fall into three broad groups: 1) measuring PWV, 2) 
relating change in diameter or area of an artery to distending 
pressure, and 3) assessing arterial pressure waveforms. The most 
hallowed measure of arterial stiffness is pulse wave velocity (PWV). 
PWV is inversely related to distensibility and can be calculated using 
the Moens-Korteweg equation: PWV = V(Eh/2pR), where E is
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Young's modulus of the arterial wall, h is wall thickness, R is arterial 
radius at the end of diastole, and p is blood density. There are a 
number of ways to measure PWV, and these are generally easy to 
perform. For example, the arterial pulse wave is recorded at a 
proximal artery, such as the common carotid, as well as at a more 
distal artery such as the femoral. The superficial location of the 
carotid and femoral arteries means that their pulse waveforms are 
readily measured non-invasively, and between these two sites the 
pulse wave travels through most of the aorta. PWV is measured as 
the delay between corresponding points on the wave, which are not 
influenced by wave reflection between two recording sites in the line 
of pulse travel. The time delay between the arrival of a predefined 
part of the pulse wave (the wave front/foot or initial upstroke is the 
usual point of reference in the two waveforms83) at these two sites 
is obtained either by simultaneous measurement, or by recording 
the waveforms independently but comparing the time delay at both 
sites against a simultaneously measured QRS complex. The distance 
travelled by the pulse wave is measured over the body surface and 
PWV is then calculated as distance/time (m/s). Arterial pulse waves 
can be detected by using pressure sensitive transducers83, Doppler 
ultrasound (the pressure pulse and the flow pulse propagate at the 
same velocity) or by applanation tonometry, where the pressure 
within a small micromanometer flattened against an artery equates 
to the pressure within an artery84. Practical problems in
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measurement of PWV arise when convenient points of measurement 
(e.g., carotid and femoral artery) are not in the same line of travel, 
and in determining the actual arterial distance between recording 
sites form measurements on the surface of the body.
Pulse W ave Velocity
The "anatomical area" of the arterial tree determines the pulse 
wave velocity. It is usually recorded in metres per second (m/s). 
Higher velocity corresponds to higher arterial rigidity and therefore 
to lower arterial distensibility. The principal determinants of PWV 
are the elastic properties of the arterial wall, blood pressure and 
blood viscosity. PWV is generally greater in peripheral than central 
vessels due to differences in elastic properties and blood pressure 
amplification. Systolic Blood pressure in youth is lower in the aorta 
than in the periphery and as pressure increases so does PWV. 
Systolic pressure increases as we descend the arterial tree, but 
diastolic pressure remains constant, thus there is an increase in 
pulse pressure and PWV (Fig 1.3)85,86. The internal cross sectional 
area of the aorta has been measured87 at approximately 3 cm2 
whilst the smaller femoral arteries are as low as 0.17 cm2. Also the 
ratio between arterial radius and wall thickness (Wall thickness 
/radius) increases with increasing distance from the aorta, 
especially in the elderly.88
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Fig 1.3 Pulse W ave Velocities measured at D ifferent
Anatomical Sites85,86
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Blood viscosity and density is known to increase with higher rates of 
shear stress in smaller tubes when compared to larger ones89. 
However, this diminution with vessel size does not begin until the 
internal diameter is less than 1mm and persists until the vessels are 
smaller than 10 microns. The elastic properties of the arterial wall 
represent the ratio between stress/strain and this reflects the 
properties of the vessel walls. The major elastic properties of the 
arterial wall are determined by collagen and elastin90. I t  has been 
argued that smooth muscle also contributes to elastic properties but 
it is not a tru ly elastic material, nevertheless it does contribute to 
wall tension90. The proximal aorta has a large amount of elastin 
when compared to collagen, but further from the heart the
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elastic/collagen ratio switches. In peripheral arteries collagen and 
smooth muscle cells dominate, with elastin present in very low 
amounts (<10% ). The elastic properties of elastin are much higher 
than that of collagen, so with increasing distance from the heart 
arterial stiffness increases. At systolic blood pressure <200 mmHg 
elastin fibres mediate the majority of the stiffness of the artery 
whilst at higher pressures (SBP>200) collagen fibres are principally 
responsible, thus allowing for arterial expansion at normal 
pressures, but preventing rupture at higher pressures. These 
factors (blood pressure, viscosity, relative wall thickness and the 
elastic properties of the arteries) explain the increasing PWV at 
distal sites when compared to central PWV. PWV is primarily 
determined by the elastic properties of the artery as the pulse wave 
propagates against its walls. There are however many physiological 
and pathophysiological conditions that can increase and decrease 
velocity. These factors include age, blood pressure, heart rate and 
gender.
Age has a profound effect on both central and peripheral PWV, PWV 
increases gradually until the fourth decade but above this age the 
aortic PWV in particular appears to increase at a much faster rate 
than over the previous decades (Fig 1.4). Aschoff demonstrated 
that when an aorta was released from its vertebral attachments and 
then sliced transversely through its midpoint the cut ends would
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retract. In youth the cut ends retracted significantly further than in 
the elderly, suggesting a loss of recoil in the arterial wall with age88, 
91. Also with increasing age the size of the aorta increases while 
extensibility decreases. Further studies have shown that
collagenous tissue replaces elastic tissue in the aorta as age 
increases. We are born with all the elastin we will ever have in our 
arteries, it is broken down with a Vh of 30 years92,93.
Fig 1.4 Age related changes in Aortic PWV94
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A study carried out in a Chinese population assessed brachial PWV, 
femoral PWV and aortic PWV across a large age range. Brachial 
PWV exceeded femoral PWV, which exceeded aortic PWV95. 
However, as the group aged the difference between the velocities 
become closer, because aortic PWV increases with age at a greater
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rate than peripheral PWV95. This data agrees with the higher rate of 
atherosclerosis in the central arteries when compared to the 
periphery with increasing age. There are numerous studies 
independently demonstrating that the elasticity of an artery and 
PWV are both affected by changes in blood pressure83,96,97. Studies 
in large populations have shown that age and blood pressure are 
the two major factors influencing PWV95. Age has a greater effect 
on aortic than on brachial or femoral PWV.
Studies examining the effects of heart rate on PWV have yielded 
inconsistent results. Sands et al observed no change in PWV with 
heart rates up to 150 (bts/min) (13.32 m/s at heart rate of 92 and 
13.38 m/s at a heart rate of 150)97. This was also the case when 
subjects with A-V block were compared at paced and non-paced 
rates98. In both these studies the PWV was exceptionally high and 
the methodologies used are open to question. Over the last decade 
other studies have shown that basal PWV is related to resting heart 
rate99"101. This may be a function of fitness status, as we know that 
both heart rate and PWV increase with worsening physical 
capacity102, 103. However in other recent studies pharmacological 
agents or pacing have been used to alter heart rate and these too 
have clearly shown that an increase in heart rate causes a 
concomitant increase in PWV. Liang et al showed that increasing 
heart rate (transoesophageal pacing) from 56 to 80 and then 100
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(bts/min) resulted in significant increases in carotid to femoral 
(aortic) and femoral to dorsalis pedis PWV104. The increase in lower 
limb PWV was only significant when increasing heart rate from 56 to 
80 (P<0.05), whilst the aortic PWV was significantly different at all 
three heart rates104. It  should be noted that mean blood pressure 
(MBP) rose from 78 to 98 (P<0.05) and then to 102 (P=NS) 
(mmHg) during chronotropic stimulation, providing a confounding 
variable and hampering interpretation of the effect of heart rate 
alone. There have been numerous studies which have corroborated 
these results in both normotensive and hypertensive subjects101,105, 
106. In contrast, Wilkinson et al have claimed to show that aortic 
PWV does not change with pacing (80-120 bts/min)107. They used 
the timing of the reflection wave (TR) to estimate PWV. Although TR 
has been validated as a method for estimating PWV the error 
around this measurement (Approx 0.5 m/s) make it unreliable as an 
accurate determinant of PWV. Reflectance site as well as PWV 
influences TR.
One reason why increasing heart rate may increase PWV is the 
reduction in left ventricular ejection time (LVET) associated with 
increasing heart rate. Nurnbeger et al studied 102 young healthy 
men. From this cohort, 6 subjects who had been given a -  
methylnoradrenaline, were also given the p and alpha 
adrenoreceptor stimulator yohimbine and the p antagonist
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propranolol. Basal PWV was related to age and LVET using multiple 
regression analysis (PWV was also related to heart rate using simple 
regression analysis (r=0 .245/ P=0.0125))10°. Beta stimulation 
change in delta LVET was associated with delta PWV using simple 
regression analysis (r = -0.520, P= 0.0325), alpha stimulation 
produced significant correlations on simple regression between Age, 
DBP, HR, LVET and others (all P<0.05) whilst the multiple 
regression showed correlations between age, DBP and LVET only (all 
P<0.05)10°. Most studies investigating gender differences in PWV 
have tended to show that women have a slightly lower PWV (5% ) 
throughout early and mid-life until they reach the menopause where 
this difference is no longer evident. These gender differences are 
more marked in the peripheral arteries than in the Aorta, see Fig 
1.5. As noted above PWV is linked with age, blood pressure and 
other cardiovascular risk factors, however there is still a question of 
cause and effect and whether this means that PWV is a valid marker 
for risk of future CHD. In 1996 Suzuki published the results from a 
large study (n >100,000) carried out in Japanese urban residents 
from 1983 to 1986108. During the follow up (2-years) there were 
301 cardiovascular events. The results showed that blood pressure 
and Carotid-Femoral PWV were independent predictors of events in 
a multivariate model. Blacher et al showed that aortic PWV was 
significantly correlated with estimated risk for myocardial infarction, 
CHD, CVD and stroke (derived from the Framingham scoring
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system)37. Aortic PWV correlated more closely with the 
Framingham risks than LV hypertrophy, plasma creatinine or 
total/HDL cholesterol. From the ir data they suggested an optimal 
cut off point of 13 m/s to predict ten-year CV events. This group 
have also published data showing tha t subjects with end-stage renal 
disease who have a raised aortic PWV (>12, m/s) have a 5.4 Odds 
ratio (Cl 2.4-11.9) fo r all cause m orta lity and 5.9 for cardiovascular 
m ortality (Cl 2.3-15.5), when compared to subjects with an aortic 
PWV of <9.4 (m /s). They also showed that for every 1 m/s 
increase in PWV the increase in all cause m ortality odds ratio was 
1.39 (Cl 1.19-1.62)38. These studies have shown the prognostic 
significance of aortic PWV in selected patient groups, and suggest 
the possibility of Aortic PWV being used as part of a multi-factorial 
stratification in apparently healthy subjects.
Fig 1.5 Aortic and Radial Pulse W ave Velocity for
Age and Sex
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Peripheral and Central A rteria l Blood Pressure
Historically the measurement of blood pressure has been from the 
brachial artery109, however there are significant differences 
between aortic blood pressure and peripheral blood pressure with 
particular reference to Systolic Blood pressure110, m . Diastolic and 
mean blood pressures are not usually significantly different in 
health110, m . The reason for this is due to pressure wave reflection 
that results in amplification of peripheral systolic pressure. There 
are recent studies that demonstrate that this amplification increases 
on exercise and has been shown to be as high as 80 mmHg12. 
However given the complex nature of the equipment and the 
movement artefact involved in pulse wave analysis, brachial artery 
sphygmomanometery remains the gold standard for exercise blood 
pressure. It  has been shown to yield reproducible results when 
carried out by a trained operator and has reasonable agreement 
between observers. For our purposes the same trained operator 
carried out all blood pressure measurements.
Early invasive studies assessing peripheral and central artery 
waveforms showed striking discrepancies between the peripheral 
and central blood pressure on exercise12, m . Interestingly Rowell 
noted also that exercise had a marked effect on the shape of these 
waveforms during exercise, the main finding was a reduced 
amplification of central pressure, which was magnified with
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increasing intensity12. Theoretically this was suggested to be due to 
a peripheral vasodilation and reduction in positive waveform 
reflections.
Pressure W ave Analysis
Modern clinicians on the whole pay little attention to the pulse wave 
itself, rate and rhythm apart, but it was originally studied in the late 
19th century by Dr Mohamed, initially as a medical student in 
London. It  was Dr Mohamed who developed the original 
Sphygmogram, this was a mechanical device which used levers to 
"draw" the peripheral pulse wave, in this case the radial artery 
waveform112. Mohamed showed that changes in peripheral 
waveforms were demonstrable following pharmaceutical 
intervention and that there were difference in health and disease. 
However the arrival of sphygmomanometery and the ease of 
application resulted in a reduction in the number of patients 
receiving sphygmogrametry.
The invention of high fidelity tonometers and hence "Applanation 
tonometry" has resurrected interest in this field. The radial artery 
has become the most used site of application and the application of 
a validated mathematical transfer function, which generates aortic 
waveforms and pressures from peripheral waveforms, has lead to 
widespread clinical use113, 114. The transfer function is still
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questioned but it is becoming accepted that central systolic blood 
pressures are accurate and any inaccuracy probably stems from the 
error in the peripheral calibration pressure rather than the transfer 
function itself. There is still no consensus on the accuracy of the 
transfer function for central augmentation index and recent studies 
have shown that peripheral augmentation is at least as accurate as 
central estimates and could therefore be used instead.
Fig 1.6 Aortic W aveform  and Augm entation In d ex
Augmentation Index (Al) is calculated as the difference between the 
early systolic shoulder (P I) and the late or peak systolic shoulder
(P2), the augmentation
P2
PP
ED
index was then 
calculated as the 
difference in systolic 
shoulders (P2-P1) 
divided by the pulse 
pressure and
expressed as a 
percentage.
Arterial W ave Reflection
The left ventricle contracts and ejects blood into the circulation, this 
creates a primary wave of forward travelling pressure. When 
assessing the peripheral pulse wave there is a second pressure 
wave and occasionally a third. The secondary pressure is largely
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due to reflections of the initial wave and is smaller in magnitude 
than the primary wave but increases as the waveform reaches the 
periphery115. Wave reflections occur at branch points of the arterial 
tree and the reflected waves in the large vessels are the 
accumulation of the peripheral reflections. In health this wave 
reflection arrives during the diastolic phase of the cardiac cycle and 
augments diastolic coronary perfusion and does not negatively 
impact on ventricular ejection by increasing afterload46.
In many disease states the arteries stiffen and pulse wave velocity 
increase. This increase in velocity and amplitude of the reflected 
waveforms can result in the returning waves arriving during the 
systolic component of the cardiac cycle115, 116. This results in an 
augmentation of the systolic pressure wave and can increase 
ventricular load and hence oxygen consumption. This increase in 
arterial pressure can be measured as the aortic augmentation index 
that is the augmentation pressure divided by the pulse pressure as 
depicted above (Fig 1.6).
Exercise and Pulse W ave Velocity
Exercise can of course be separated into acute exercise (Single 
bouts) and chronic exercise (Multiple bouts) and we would expect 
there to be different reactions to each. It  can also be separated 
into aerobic (cycling, walking etc) and anaerobic (resistance
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training, sprints etc) exercise, which are different in terms of 
intensity and duration. This review will concentrate mainly on acute 
and chronic aerobic exercise and its effect on markers of arterial 
function.
Chronic Exercise and Pulse W ave Velocity
Whilst aortic PWV was lower in athletes > 20 years old versus age 
matched sedentary controls, no differences were observed in 
younger subjects (Table 1.4)117. As the study demonstrates, older 
trained athletes have lower PWV than younger sedentary subjects. 
These data suggest that aerobic training reduces the 
pathophysiological effects of ageing on arterial stiffness.
When PWV and augmentation index (Aix, which is a measure of the 
effect of the reflected waves on systolic pressure) are analysed for 
the effect that they have on maximal exercise capacity there is an 
inverse relationship between both factors and exercise capacity. In 
the endurance-trained athletes the slope of this relationship was 
flatter, implying a delay in the age related decrease in fitness and 
arterial function117. In patients with dilated cardiomyopathy the 
aortic distensibility independently predicted exercise capacity (r= - 
0.39, p=0.0007) and in a multivariate model Aortic PWV and stroke 
volume accounted for 34% of the variance in V o 2max118. When the 
carotid, brachial and femoral arteries of elite cyclists were compared
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to sedentary controls there was no difference between groups in 
carotid distensibility, but the brachial and femoral distensibilities 
were significantly greater in the cyclists119. This demonstrates a 
specific adaptation to the increased flow in the exercising limbs in 
this athletic population. Conversely Gauthier and colleagues 
showed that the resting BPWV was significantly higher in the arm in 
athletes than controls, suggesting decreased distensibility120. The 
authors felt that this finding may explain why competitive athletes 
sometimes develop cardiac hypertrophy (although they did not 
demonstrate athletic hypertrophy in this study). In a cross- 
sectional study involving 56 fun runners, 25 active subjects (>1500  
kcal/week) and 83 control subjects (<1500 kcal/week) Kakiyama et 
al showed that the Aortic Pulse Wave Velocity Index (APWVI = 
Aortic PWV scaled for DBP) was negatively correlated with habitual 
physical exercise, as analysed from a seven day activity form121. 
They also showed that after accounting for age, the APWVI was 
significantly lower in the sub-group of runners compared to the 
active and sedentary groups and that the active group was 
significantly lower than controls. Tanaka et al confirmed these 
findings in pre and postmenopausal women. They showed that 
central markers of arterial function (Ai and Aortic PWV) were 
significantly lower in active women when compared to control but 
that peripheral markers (brachial an femoral PWV) were not 
different between the groups122. These observations demonstrate
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that central arteries stiffen with increasing age much more than 
peripheral arteries and that this stiffening can be reduced by regular 
physical activity in women. In other studies in men central arterial 
compliance and p-index (a BP-corrected measure of aortic 
compliance) was shown to be 20-35%  higher in endurance-trained 
subjects than in age-matched controls123,124.
A small number of studies have prospectively assessed the effects 
of exercise training in sedentary subjects. The Melbourne group 
carried out a randomised crossover study of four weeks training and 
four weeks de-training at 75% of maximal workload125. They 
showed that baseline systemic arterial compliance (sac) increased 
by an average of 0.26 (Arbitrary Compliance Units (ACU)) and that 
p-index decreased by an average of 1.03 following training. The 
increase in SAC was greater than could be explained by the 
reduction in blood pressure observed and the authors concluded 
that exercise training must cause an intrinsic alteration of arterial 
compliance. Subsequently Higashi et al showed that 12 weeks of 
walking for half an hour each day at an intensity equivalent to 52%  
of V0 2 max, in hypertensive and normotensive subjects, elicited 
increases in forearm blood flow in response to acetylcholine (25.8 to 
32.3 ml.min/lOOml tissue, P<0.05) but no change in the response 
to the non endothelium dependent vasodilator isosorbide dismitrate, 
indicating an enhancement of endothelium dependent
59
vasodilatation, which was blocked with L-NMMA, a specific Nitric 
Oxide Synthase inhibitor126. This improvement in endothelial 
function with exercise training may at least in part explain the 
improvement in large artery stiffness. However data from the 
"Melbourne group" showed that an eight week exercise training 
programme (Cycle ergometry at 65% of MHR for 40 minutes three 
times a week) in hypertensive (ISH) subjects did not alter SAC 
(0.35 vs. 0.38 A.C.U, p=ns) 127 carotid femoral PWV (11.5 vs. 11.5 
m/s, p=ns) or femoral-dorsalis PWV(9.02 vs. 9.23 m/s, p=ns) even 
after increasing V02max from 21.4 to 24.3 (ml/kg/min) (p<0.05 )128. 
Studies in patients with chronic heart failure, who exhibit an 
impaired endothelial dependent vasodilation, have shown that L- 
Arginine supplementation129, aerobic exercise training81, 82, 130 and 
also combining training and supplementation correct endothelial 
dysfunction as assessed by radial artery diameter responses to 
Acetylcholine and Nitroglycerin79.
Resistance Training
Although resistance training (Weight Training) is another form of 
chronic exercise it has been shown to have a negative impact on 
arterial function. Miyachi et al showed that in older men (40-60) 
who had resistance trained for an extended period of time (> 2 
years) carotid arterial compliance was lower (0.11 vs. 0.15 p<0.05) 
when compared to age matched controls, but that no such
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difference was seen between the young group (20-39) and controls 
(0.16 vs. 0.19, p=ns)131. They also showed that this decrease in 
compliance was associated with left ventricular hypertrophy. 
Bertovic et al assessed left ventricular mass (LVM), SAC, p-index 
and aortic and femoral PWV in strength trained versus control 
subjects132. They showed a significant increase in LVM and femoral 
PWV and a decrease in SAC and p-index in the resistance trained 
group when compared to controls (P<0.05 for all), conversely they 
showed no differences in Aortic PWV between groups (p=ns).
Acute exercise and Pulse W ave Velocity
Sebban et al evaluated PWV in elderly women and demonstrated 
that for a higher resting PWV, sub-maximal oxygen consumption 
and heart rate were significantly elevated at rest and during 
exercise when compared to those with a normal PWV133. This is 
probably due to the greater force needed to overcome the early 
returning waves from the periphery associated with the stiffening 
arteries and increased PWV. However the exercise was a 400m run 
which is neither wholly aerobic nor anaerobic and thus leaves the 
interpretation of this data open to methodological questioning134. 
Murgo and colleagues measured PWV invasively during supine 
exercise and demonstrated that aortic PWV increases during 
exercise, implying decreased compliance, despite a fall in total 
peripheral resistance from 1142 to 712 (dynes/cm5). In this study
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they demonstrated that the timing of the returning wave (T r) from 
the periphery was shorter during exercise than at baseline135. 
Although an interesting finding, any increase in heart rate, and 
therefore a subsequent reduction in total waveform duration, will 
always lead to a reduced T r when expressed in milliseconds, as was 
the case with this study.
Table 1.4 Influence o f age and tra in ing  on Aortic Pulse 
W ave Velocity117
Age (Years) Untrained
(m /s )
Trained
(m /s )
P Value
10-19 6.17 6.17 P=NS
20-29 6.88 6.48 P<0.05
20-39 7.41 6.71 P<0.05
In the mid 1950's Simonsen and colleagues looked at aortic PWV 
pre and post-moderate treadmill exercise (3 m.p.h and 5% 
gradient), and observed no differences136. Recently our group 
demonstrated that after a maximal exercise test to volitional 
exhaustion, subjects who were free of cardiovascular disease 
showed a marked reduction in Femoral PWV137. This reduction 
lasted for up to an hour and implies an increase in femoral arterial 
distensibility following acute maximal exercise. Kingwell and 
colleagues demonstrated that half an hour after a single bout of 
cycle exercise (65% of V02max) aortic (6.2 vs. 5.9 m/s, p<0.05) 
and femoral PWV (8.3 vs. 7.5 m/s, p<0.01) were both reduced and 
whole body arterial compliance was increased (0.9 vs. 1.4 ACU, 
p<0.05) compared to baseline138. Chen and colleagues have shown
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that in elderly subjects with increased arterial stiffness and reduced 
exercise capacity, administration of Verapamil reduced baseline 
PWV and augmentation index (-5 .9  and -31.7% respectively, 
p<0.05) and increased time to anaerobic threshold and maximal 
exercise capacity (48 and 13.4% respectively, p<0.05)139. In a 
recent study Suguwara et al have shown that acute single leg 
cycling at a very low intensity (20-30 watts for 5 minutes) reduces 
femoral PWV in the exercising (9.1 vs. 8.4, p<0.05) but not in the 
contra lateral non-exercising limb (9.0 vs.9.2, p=ns)140. Thus local 
exercise related factors (Nitric Oxide, adenosine, prostaglandins) 
might be responsible for the post exercise reduction in PWV, in the 
exercising limb.
Aerobic Exercise Physiology
Aerobic exercise is commonly described as continuous rhythmical 
exercise of a large muscle group or groups over a sustained period 
of time, where aerobic metabolism provides the majority of ATP 
needed for cross bridge activation. The gold standard for 
measuring aerobic capacity ( V o 2max) is an incremental exercise test 
to volitional exhaustion, usually on a treadmill or cycle ergometer 
with breath-by-breath online analysis of oxygen consumption and 
carbon dioxide expiration. V o 2max is determined by two factors, the 
maximal cardiac output (CO m ax) and the maximal arterio-venous 
oxygen difference (A -V o 2diff). Numerous factors can affect either
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the COmax or the A-Vo2diff. This has led to considerable 
disagreement between exercise physiologists as to which of the two 
factors (C O max and A-Vo2diff) is responsible for limiting Vo2max.
VO max =  COmax X A-V02diff 
COmax — SVmax x HRmax 
SVmax = End diastolic volume -  End systolic volume 
A-Vo2diff = Arterial oxygen load -  Venous oxygen load
We outline below the evidence gathered over the previous eighty 
plus years in relation to factors limiting maximal aerobic capacity.
As early as 1923 maximal cardiac output was indicated as the major 
rate-limiting step to V0 2 max141, 142. Since then maximal cardiac 
output (COmax ) has been shown to account for up to 85% of the 
variation in V02max143. However, in recent years there has been 
disagreement between leading physiologists as to whether it is 
central or skeletal factors that limit V02max144’ 147.
Evidence for cardiac output as the ra te-lim iting  step in 
aerobic exercise
COmax in healthy adults is determined by maximal stroke volume 
(SVm ax) and heart rate (HRmax). Maximal heart rates have been 
demonstrated to be similar18 and in some cases lower148 in
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endurance-trained athletes, when compared to sedentary controls. 
This indicates that the SVmax may be the limiting factor to COmax.
There is clear evidence to indicate that CO is unable to increase 
further at maximal exercise. These studies have shown that the 
recruitment of additional muscle groups to the already maximal 
working lower body muscles results in no further increase in CO 
with only a slight increase in V0 2 max due to a greater arterio-venous 
oxygen difference (A-V0 2diff) between the resting arm's and the 
exercising arm's149151.
The administration of beta blockade, which decreases heart rate and 
marginally increases stroke volume, resulting in a lower CO by 
approximately 20%, has been demonstrated to lower V0 2 max- V0 2 max 
decreases by only 5-15% in contrast to the CO drop of 20%, the 
difference is probably attributable to a slight increase in A-V0 2 ditr, 
suggesting that A-V0 2ditf is not usually at maximal levels and 
therefore not the limiting factor152"154.
Data from Rowell demonstrates that the main difference between 
athletic and non-athletic healthy subjects is maximal stroke volume. 
As shown in table 1.5, both maximal heart rate and A-V02ditf are 
similar between the athletic and non-athletic subjects. It  is the 
83% larger stroke volume which produces a 78% larger COmax
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(38.95 V's 21.84 L/min"1), that accounts for the 78% difference in v
02max18-
Table 1.5 Athletic and non-ath letic haemodynamics a t
VOzmax18
V02max Heart Stroke A-V02diff
(L 's /m in ) rate volum e (m l's /1 0 0 m l)
(B e a ts / (m l's )
m in)
Athletic 6.25 190 205 16
Non-athletic 3.50* 195 112* 16
* = Significant difference between groups
In addition to having a lower maximal stroke volume the non- 
athletic subjects stroke volume reaches its maximal value at a heart 
rate between 120-140 (Beats/min) compared to athletic populations 
whose stroke volume can continue to increase to maximal heart 
rates20. Therefore, further increases in cardiac output can only be 
achieved through an increased chronotropic drive. This plateau in 
stroke volume is attributed to the decrease in end diastolic volume 
as a result of a decreased diastolic relaxation time20
The most conventional way to increase V02max is by aerobic 
exercise. In 1968 Ekblom and co-workers demonstrated that a 530 
(m l/m in1) increase in oxygen consumption following a 16-week 
training programme increased COmax by 8% while A-V0 2 diff only 
increased by 3.6% 155. The classic bed rest study of Saltin and 
colleagues has shown similar findings after 30 days of training
following extended bed rest156. Perhaps the strongest evidence for 
oxygen supply limitation (CO) not oxygen demand is demonstrated 
by comparing exercise of a small muscle mass (leg extension) to 
that of a large muscle mass (cycle ergometry). When exercising a 
small muscle mass (2.5-6kg) CO will not be a limiting factor 
therefore the oxygen consumption of the leg should remain the 
same if A-vo2diff was a limiting factor. Contradicting this hypothesis 
is that oxygen consumption of that muscle is approximately 600 
ml's (0 2 /kg /m in 1) during exercise of a small muscle group157. In 
contrast, during exercise of the same muscle group during whole 
body exercise this value is 250 ml's (0 2 /kg/min"1)158. The primary 
reason for this increase in oxygen consumption is the increase in 
blood flow to the working muscle (quadriceps), it was measured as 
1.5 (Lykg/min'1) by Knight and colleagues in 1992 during maximal 
cycling ergometry158. During leg extension exercise the blood flow 
to the quadriceps increases to 3.9 (lykg/min as measured by 
Richardson and colleagues in 1995157, 159. This allows us to 
postulate that the 240% increase in leg V02  during leg extension 
can be attributed to the 260% increase in cardiac output with a 
slight reduction in A-Vo2diff (16.6 cycling V's 15.3 leg extension). 
This reduction in A-Vo2diff was believed to be due to the decreased 
transit time through the capillary beds, though this has been 
reported as not being the case160,161. It  is important to note these 
experiments used the same technique to quantify muscle oxygen
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consumption and blood flow. These experiments show us that when 
muscle blood flow and therefore oxygen delivery is increased that 
maximal oxygen consumption of the quadriceps muscle increases, 
demonstrating a central (Cardiac output) not peripheral (Skeletal 
muscle) limitation to whole body (Large muscle mass) exercise.
Evidence for skeletal metabolism as a determ inant o f Vo2max
Capillary density increases with exercise training and strongly 
correlates with V0 2 max, enabling the muscle to maintain A-Vo2d\ff at a 
high cardiac output by reducing capillary transit times162, 163. A 
common example used to argue that skeletal muscle can limit 
maximal exercise is the increased number of mitochondria following 
exercise training. However despite the large increase in 
mitochondria density post exercise training and the strong 
correlation between Vo2max and mitochondria density the 
proportional increase varies markedly. Saltin et al demonstrated 
that for a 220% increase in mitochondria there is only a < 40%  
increase in V0 2 max156. More recently it has been demonstrated that 
subjects with a similar Vo2max may have marked differences in their 
mitochondrial volumes and Coyle et al suggested that mitochondria 
were more important for endurance performance rather than for 
maximal exercise164.
Does the P02 o f the cell lim it the rate o f oxygen uptake?
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Until recently is has been very difficult to examine the P0 2  of a 
muscle cell during dynamic exercise but with the use proton 
magnetic resonance spectroscopy this has become achievable. In 
1995, Russell Richardson et al demonstrated for the first time that 
there are large differences between blood and intracellular tissue 
P02  and that this gradient is highly significant in determining oxygen 
uptake by the muscle157, 159. Since then he and others have 
demonstrated that it is only at very high metabolic rates that we 
come close to mitochondrial metabolic limits, even then by 
increasing oxygen delivery (Hyperoxic gas) metabolic rate can be 
increased165.
In conclusion, during exercise in which a large muscle mass (> 6  kg) 
has to be supplied with oxygen, cardiac output limits maximal 
exercise capacity. However, when a small muscle mass is isolated 
and flow can increase several fold the skeletal muscle 
characteristics appear to be the rate limiting step. It is important to 
note that walking, running, cycling, swimming and almost all 
commonly undertaken exercise will use a muscle mass in excess of 
6kg and therefore will be limited by cardiac output. This is 
applicable in health and in the majority of cardiovascular states, 
however in the heart failure setting there are numerous peripheral 
factors, these are beyond the scope of this review.
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Ventricular Arterial Coupling
The interaction of the left ventricle and the vascular tree, termed 
ventricular-arterial coupling is a key determinant of physical 
performance. As we have clearly outlined there is a considerable 
role for the ventricle to play in outputting blood to allow for peak 
exercise performance, however the properties of the vasculature 
also play a significant role. The healthy ventricle and vasculature 
match properties so that near maximal cardiac output is achieved 
while maintaining adequate arterial pressure, this is ventricular 
arterial (V-A) coupling166,167. The two measurable components are 
Ees (ventricle) and Ea (arterial) and the ratio of these two impacts 
on ventricular performance. Ea is a measure of both the pulsatile 
and static afterload, which is also influenced by heart rate. Ees is 
the ventricular contractile function. An Ea/Ees ratio of 0.7 to 1.0 in 
healthy humans allows for optimal stroke work, and importantly 
optimal metabolic efficiency168,169. This ratio has been as high as 
4.0 in patients with heart failure170, 171, due to a rise in arterial 
resistance (Ea) and a fall in ventricular contractility (Ees). As we 
age our arteries stiffen as was initially reported by Avolio et al, 
using PWV, and has recently been reported using Ea92, 95. 
Mechanically this increases the load on the heart and this results in 
increases in diastolic and systolic ventricular stiffness, which may 
have accompanying hypertrophy. However not all people with stiff 
arteries have shortness of breath and this is explained by the fact
70
that the ventricular systolic stiffness also increases with the 
increase in arterial stiffness and thus the Ea/Ees ratio is preserved.
Although this preservation of coupling works within normal ranges 
and under normal physiological stimuli, it may affect cardiac 
reserve. The increase in Ea and Ees reduces left sided compliance 
resulting in a greater change in pressure for any given volume 
change. So as we exercise and increase venous return and diastolic 
filling we get a far greater increase in systolic developed pressure, 
this results in dramatic variations in arterial pressures and thus 
haemodynamic instability. During exercise the normal heart 
enhances output with maintenance of preload and an increase in 
systolic contraction. Ea typically rises due to heart rate and arterial 
pulsatility, even in the face of a fall in total peripheral resistance172. 
To match this the healthy heart usually increases its ventricular 
contractility to maintain the V-A coupling, however if resting Ea is 
already risen, as is the case with age and in heart failure, there is 
less reserve and any increase in Ea will only exacerbate the systolic 
pressure rises and decrease cardiac efficiency and increase 
metabolic demands173.
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Overview
As we have outlined coronary heart disease is the single most 
influential disease in the Western world, and that blood pressure, be 
it pulse, diastolic, mean or systolic is linked with the risk of 
m ortality and morbidity. Recent investigations have tended to 
assess systolic and pulse pressure, as they appear to have greater 
prognostic information that other measures of blood pressure. As 
these pressures are markedly influenced by arterial function it is 
unsurprising to note that arterial stiffness per se is also influential in 
the prognosis of chronic disease. Theoretically, at least, there is a
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link between an early stiffening of the arteries and the development 
of isolated systolic hypertension through to the more serious 
consequences of diastolic heart failure. However important the 
understanding of the pathophysiology in these disease states is, we 
must have a solid base to examine these changes against and as 
outlined due to methodological and patient populations there are 
still questions as to the normal arterial responses to the different 
modalities, intensities and duration of exercise. It  is also apparent 
that an Exaggerated Systolic Blood Pressure response to exercise is 
also a risk factor for hypertension, stroke, myocardial infarction and 
mortality and that this may be an early marker of disease or even 
arterial dysfunction. Once these normal responses have been 
determined we can look at the two key components of arterial 
control; the sympathetic nervous system and the endothelium in 
particular the role of Nitric Oxide.
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Chapter 2
Physiological Measurements
Overview
It cannot be overstated the importance of understanding 
physiology, however physiology cannot be understood without the 
use and understanding of accurate and reproducible measurements. 
The aim of this chapter is to give an accurate and thorough 
understanding of the techniques that we used, the subsequent 
analysis that we carried out and the accuracy of our measurements.
Arterial Function
We used three techniques to assess arterial function in this thesis. 
In summary they were peripheral pulse wave velocity (Femoral and 
Brachial) using an oscillometric technique, aortic pulse wave 
velocity (Carotid-Femoral) and Pulse Wave Analysis both from the 
Sphygmocor system.
Pulse W ave Velocity
Pulse wave velocity (PWV) is defined as the speed of an arterial 
pulse wave as it travels from an initial arterial segment to a second 
segment along the same arterial tree. PWV is simply calculated as 
distance travelled (m) divided by time (s) and expressed as metres 
per second (m/s)
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Peripheral Pulse W ave Velocity (Chapters 3 -6 )
We used one system to measure Brachial-Radial and Femoral-Tibial 
Pulse Wave Velocity (BPWV and FPWV respectively). We measured 
FPWV and BPWV simultaneously and non-invasively by oscillometry 
(time resolution + /-  2ms; QVL P84, SciMed, Bristol, UK). The right 
arm and leg were used for all measurements in these studies. Non­
occlusive cuffs were placed over the upper arm (brachial), wrist 
(radial), mid thigh (femoral) and ankle (tibial); the cuffs were 
connected to computerised pressure transducers by non-compliant 
tubing. Pulse pressure waveforms caused by volume displacement 
were obtained from each of the four cuffs. A computer programme 
was developed to characterise the waveforms with respect to time 
at 30, 40 and 50% of peak pressure along the ascending limb, this 
then calculated the transit time between the cuffs. The transit 
times are the average of the 3 points (30, 40 +50) of ten 
continuous waveforms. PWV was then calculated by dividing the 
distance between the proximal points of each of the cuffs (mm) by 
the transit times (ms). This process was repeated every sixty 
seconds for periods of up to 15 minutes.
A colleague, Dr Nicholas Pegge, previously assessed this system. 
He investigated the changes in PWV following reactive hyperaemia 
(PWV minus PWV post reactive hyperaemia). BPWV and FPWV 
decreased in response to reactive hyperaemia ((7.3 to 6.4 and 8.7
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to 7.6 m/s) (p<0.001) respectively) in keeping with endothelial 
control of large artery distensibility and the NO synthase inhibitor 
LNMMA blocked this response. PWV returned towards baseline over 
the subsequent 20 minutes. During L-NMMA infusion resting BPWV 
was increased by 0.8 (m /s) and the response to reactive 
hyperaemia decreased from 12.3% to 7.9% (P<0.005). Nitro­
glycerine (GTN) administered 15 minutes after the last cuff 
measurement and following the L-NMMA infusion reduced BPWV by 
18.1%. In addition it was shown that differences in PWV post 
reactive hyperaemia are correlated with other cardiovascular risk 
factors in a healthy population adding further evidence that changes 
in PWV following reactive hyperaemia are endothelium dependent.
Aortic Pulse W ave Velocity (C hapter 5 )
Aortic pulse wave velocity (AoPWV) was determined by applanation 
tonometry and timed using the electrocardiogram. Applanation 
tonometry was performed using a Millar piezo-resistive pressure 
transducer (Millar SPT 301, Millar Instruments) coupled to a 
SphygmoCor device (PWV Medical, Australia), attached to a 
computer with specialised software (SCOR 2000, Version 7.0). 
AoPWV was calculated by sequential acquisition of the pressure 
waveforms from the carotid and femoral arteries. The timing of 
these waveforms was matched with that of the 'R' wave on a 
simultaneously recorded electrocardiogram. AoPWV was
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determined by the calculation of the differences in carotid to 
femoral path length divided by the difference in R wave to 
waveform foot times. The difference in carotid to femoral path 
length can be measured in two ways. The first is the distance from 
the sternal notch to the femoral pulse (At the point of the 
applanation tonometer) measured in a direct line, this reduces 
between observer errors but reduces AoPWV by about 10%. The 
second method is the same sternal-femoral path length minus the 
distance from the sternal notch to the carotid pulse (At the point of 
the applanation tonometer). This allows for a more direct 
calculation of AoPWV but with a slightly higher level of between 
observer errors84. As we used the same operator for all studies, we 
used the femoral-carotid path length.
Pulse W ave Analysis (P W A ) (Chapters 5 and 6 )
Radial artery pressure waveforms were acquired and central 
pressure waveforms were generated using pulse wave analysis 
(SphygmoCor, AtCor Medical). The pulse wave analysis transfer 
function has been validated under differing haemodynamic states 
and recently during supine, low level exercise. The central 
waveform yields central aortic pressures (CBP), augmentation index 
(AI), heart rate corrected augmentation index (AI@HR75) and the 
timing of the reflected wave (TR). There have been studies84, 174
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demonstrating the reproducibility and accuracy of these readings 
and a subset of the findings are reproduced in table 2.1
Central Blood Pressures (CBP) were derived using a mathematical 
transfer function that generates an aortic pressure waveform from 
the recorded radial waveform. This transfer function has been 
validated against invasive aortic pressure measurement at rest, 
during valsalva and from lying to sitting175, it has also recently been 
validated during low level supine exercise176.
Augmentation Index (AI) is calculated as the difference between the 
early systolic shoulder (P I) and the late or peak systolic shoulder 
(P2), the augmentation index was then calculated as the difference 
in systolic shoulders (P2-P1) divided by the pulse pressure and 
expressed as a percentage. As heart rate has been shown to affect 
augmentation index a correction factor was applied to the reference 
value augmentation index to a standard heart rate of 75 (AI@75).
Timing of the reflected wave (TR) is a measure in milliseconds of 
the arrival of the reflected wave, from the periphery, at the aorta. 
There is an inverse relationship between TR and Aortic Pulse Wave 
Velocity. However it is also influenced by heart rate and by height. 
TR is measured in milliseconds from the beginning of the systolic
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upstroke, it is defined as a rapid increase in pressure during a 
plateau or decrease in pressure.
Table 2.1 In tra  and In te ro bserver repeat and reproducibility
of Sphygmocor84' 174
Repeatability
( % )
Reproducibility
( % )
Interobserver
(% )
Heart Rate 4.5 ± 1.7 9.1 ±  4.0 2.9 ± 1.7
Augmentation
Index
4.5 ± 2.7 10.3 ±  5.5 5.1 ± 3.1
Mean Systolic 
Pressure
0.8 ±  0.4 6.2 ±  3.3 3.1 ± 1.9
Mean Diastolic 
Pressure
1.1 ±  0.5 6.6 ±  2.8 3.9 ± 3.2
^Coefficients of variation for replicate measures
Haemodynamics
The importance of accurate and reproducible haemodynamic 
measures during exercise was of great importance and this was 
problematic due to the human variance in blood pressure and heart 
rate but also the large amount of noise during high intensity 
exercise.
Blood Pressure
We assessed brachial blood pressure in the non-dominant arm of all 
our subjects. One of three cuffs (Child, Adult or Oversize Adult) 
was placed over the brachial artery and tested for size. This cuff 
was attached to a freestanding aneroid sphygmomanometer 
(Accoson CE 0120) with a pressure range from zero to three
hundred (mmHg). Systolic blood pressure was defined as the first 
"beat" heard during cuff deflation (Korotkoff I), diastolic blood 
pressure was defined as the last beat heard (Korotkoff V) rather 
than when noise became muffled (Korotkoff IV). At rest, the cuff 
was initially inflated to 160 (mmHg) and then during exercise it was 
inflated 30 (mmHg) more than the previous systolic reading. 
During all measurements, the sphygmomanometer was level with 
the subject's heart and the arm was kept in a relaxed but supported 
position.
Electrocardiogram (Chapters 3 and, 4 )
We used the electrocardiogram to measure heart rate at baseline, 
during exercise and in recovery. During baseline and recovery, 
heart rate was recorded every second minute. During exercise, 
heart rate was recorded every minute throughout. The equipment 
we used (GE Marquette® Helliege Medical Systems, Model: CASE® 
16 exercise testing system, Kettering, Northants) allowed for either 
requested or automatic recoding of the ECG and heart rate at any 
given time.
Heart Rate, Stroke Volum e and Cardiac O utput (Chapters 5 
and 6 )
Cardiac Output (CO) was measured using a newly developed, non- 
invasive, bio-impedance monitor (Task Force® Monitor). This
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monitor allows determination of stroke volume (SV) and CO via 
impedance cardiography (ICG). In order to obtain the ICG signals 
DZ/DT(t) and Zo(t) new electrodes were designed. The ICG signals 
DZ/Di(t) and Zo(t) are used for the detection of stroke volume, whilst 
a newly developed signal processing tool is used to eliminate the 
electrical activity associated with breathing, to detect the maximum 
d z / dt  signal (C-point), the aortic opening point (B-point) and the 
aortic closing point (X-point)177. This tool has been validated at rest 
against other non-invasive measures (BioZ) and invasive measures 
(Thermodilution, Baxter Explorer, Edwards Critical Care, Irvine, CA, 
USA)178.
Haemodynamic and A rteria l Calculations
From the haemodynamic and arterial data measured, we calculated 
other variables using standardised cardiovascular formulae.
Pulse Pressure was calculated as the systolic blood pressure minus 
the diastolic blood pressure.
Mean Blood Pressure was calculated as diastolic blood pressure plus 
one third of the pulse pressure.
Arterial Elastance, which is a measure of the total arterial load, 
including the pulsatile and static component, but is also influenced 
by heart rate, was calculated as the derived aortic end systolic 
pressure (From PWA) divided by the stroke volume179.
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Total peripheral Resistance, which is a measure of the static 
component of arterial load, is calculated as the mean blood pressure 
(mmHg) divided by the cardiac output (L/min).
Arterial Compliance, which is a measure of the pulsatile component 
of the total arterial load, was calculated as stroke volume divided by 
pulse pressure. This has been shown to accurately estimate the 
arterial compliance calculated by the more complex area method, 
which involves using the area under the curve of the pressure 
waveform180. There were no differences in the values obtained and 
the slope and intercept did not differ with each method in either 
healthy controls or two disease groups181.
Expired Gas Analysis
Expired gases was sampled breath by breath and analysed as an 
average of thirty seconds during exercise using Pulmolab model Ex 
670 mass spectrometry gas analysis (Morgan Medical Ltd., Kent, 
UK). The system comprised of a standard PC and appropriate 
software (Morgan medical Ex670 Interface Application, Version 
1.4.1.0, release 2.11), attached to a Quadrupole Mass Spectrometer 
for gas analysis and a propeller type turbine cartridge for flow 
analysis (See table 2.2 for specifications). The theory and practice 
of gas analysis by mass spectrometry is summarised below
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Table 2.2 Mass Spectrom eter and Turbine Specifications
Quadrupole Mass Spectrom eter Propeller type Turbine
Cartridge
Sample Rate 50 data frames/ sec Resistance 0.65 cmH20/l/s 
®  8.5 L/s
Transit time 200 ms Output type Volume signal
Response 30 ms (0-90% Output 0-4 volts -  0-7 L
Time change) Signal
Detection 100 ppm Sensitivity 2.2 ml per
Limit revolution
Stability < 1%
Linearity > 1%
Sample Rate 20-50 ml/min
Gas Analysis
The equipment employs a continuous on-line quadrupole mass 
spectrometer to measure respiratory gas concentrations. Expirate 
is drawn into the tip of the sample capillary (inserted into the 
mouthpiece) at about 50ml/min, it travels the 2.5 m along the 
capillary tube and into the instrument in less than 250 ms. Inside 
the instrument, the sample passes by the high vacuum chamber 
and is drawn into a pump from which it is filtered and expelled to 
the cabinet air stream. A small portion of the sample is drawn into 
the high vacuum chamber where it is subjected to electron 
bombardment ionisation. The subsequent ions that are formed are 
projected into the influence of a complex electric field, across the 
quadrupole, which is dynamically altered to select ions of similar 
masses for short sequential periods.
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During each period, the selected ions carry a current, which is 
collected and measured, and its value digitised and stored. The 
current in each period is proportional to the ionisation efficiency and 
partial pressure of the parent molecule, in turn proportional to the 
concentration of the associated gas. Ionisation efficiencies and total 
ion pressures can be kept constant, thus a measure of each 
component of the sample gas can be got in percentage terms via 
calibration factors.
Flow Measurements
The respiratory flow rate is measured with a turbine device 
connected to the end of the mouthpiece. The construction of the 
device is such that the airscrew rotates once for every 2.2ml 
passing through, over a wide range of flow rates. The electronics 
generate a volume signal, and by measuring the incremental 
volume over the gas sampling periods, small intra-breath volumes 
can be derived. The accumulation of these volumes within the 
phases of breathing, combined with analogue input measurements, 
provides primary data for breath-by-breath calculations.
Calculations
Inspirate and expirate volumes of each gas component in the 
sample are calculated for each breath, from the integration of 
running intra-breath partial volume values, thus oxygen uptake,
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carbon dioxide production and respiratory exchange ratio are 
derived.
Calibration
For reproducibie and reliable gas analysis we calibrated both flow 
and gas analysis prior to every study. Flow was calibrated using a 
standard syringe (3/L) filled and emptied at three different speeds, 
representing changes in breathing frequency (60, 30 + 15 
Bths/min). On completion, the syringe was filled and emptied and 
the total volume of expiration and inspiration is displayed. We 
accepted calibration once readings were 1% of the syringe volume 
(2.97-3.03 L). The gas analysis was calibrated using a known 
concentration of gases. (O2 14.99%, CO2 8.12% , Ar 7.85% and N2 
69.04%). A two-stage check was then performed in which each gas 
was checked against room values (O2 20.94% , CO2 0.03% and N2 
78.9%) and again against the standard cylinder values.
Maximal Oxygen Consumption
Theoretically, maximal oxygen consumption describes an increase in 
workload without any resultant increase in oxygen consumption; 
this has been termed the oxygen plateau. Duncan et al 
demonstrated that failure to reach a plateau in V0 2  does not mean 
that a true maximal effort has not been reached182 and it is 
commonly recognised that only 50% of all subjects will reach a
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plateau183. With this In mind, it is clear that we need secondary 
criteria to establish V0 2 max when the plateau is not present. These 
criteria generally include a respiratory exchange ratio (RER) in 
excess of 1.10-1.15, a blood lactate in excess of 8 (m m ol/L1) and a 
maximal heart rate equal to 220 (Beats/m in1) -  chronological age, 
a full review of these criteria are described by Howley et al184.
Respiratory Exchange Ratio
The respiratory exchange ratio (RER) allows an accurate non- 
invasive measurement of substrate utilisation during aerobic 
exercise. RER is the ratio between expired carbon dioxide (Vco2) 
and oxygen uptake (Vo2) at the lungs. This is a different 
measurement from O2 consumption (Qo2) and CO2 production 
(Qco2) at the cellular level. RER is only an accurate reflection of 
Qco2/Q o2 (Respiratory Quotient) during steady state exercise. A 
normal resting RER (Assuming a Western diet) is approximately 0.8, 
this rises to approximately 0.95 during steady state exercise and 
then 1.0 at the anaerobic threshold. An RER in excess of 1.1 is a 
fair reflection that a maximal effort has been made in an exercise 
tolerance test.
Exercise Testing
As exercise testing was a key component of our studies we had to 
design rigorous protocols for each study that allowed the subject to
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perform to the peak of their abilities but also to allow adequate time 
and conditions for collection of accurate data.
Maximal Strength Testing
The maximal strength tests were carried out for the biceps and 
quadriceps muscles using identical protocols. For biceps testing, we 
used a single dumbbell that could be increased or decreased in 
increments of two kilogram's. For quadriceps testing, we used an 
isotonic leg extension machine where we isolated each leg; the 
resistance could be altered with increments of 2.5 kilogram's. The 
protocol we applied for the testing consisted of three warm up sets 
and then our first maximal attempt of six repetitions. If  this was 
successful, the subject chose the increment of weight increase until 
they could not complete six repetitions at the set weight. We 
completed all testing sessions in a randomised fashion.
Isom etric Exercise Test
Subjects lay supine in a custom built isometric dynamometer 
designed to measure ankle plantar flexion force. The subjects were 
positioned with the right knee flexed by 50 deg, the ankle flexed at 
90 deg, and the foot strapped to a footplate. Straps were aligned 
around the ankle in order to minimise lifting of the heel away from 
the footplate when performing plantar flexor exercise. Prior to 
each study the subjects performed maximal contractions with 2-
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minute intervals until there was less than 5% difference between 
the two peak values. This maximal value was used to calculate the 
force required for each protocol.
Dundee Step Test
The Dundee step test is a simple procedure to measure increases in 
systolic blood pressure in response to sub-maximal exercise. The 
Dundee test, as may be expected, was first used in the University of 
Dundee in a lecture theatre. They used the first step of the lecture 
hall and had students step at approximately 90 steps per minute up 
and down this step and blood pressure was recorded before and at 
the end of the three-minute period. Since then, we have
standardised the test on a 12" step, at a rate of 92 steps per minute 
(23 complete movements per minute). We measured blood
pressure at the end of the third minute and every minute after that 
until two systolic readings within 5 mmHg of each other were 
recorded.
100-W att Cycle Test
The 100-Watt cycle test was designed to duplicate the test used in 
the original Kjelsden paper in 1995. All tests were carried out on an 
upright stationary cycle ergometer ((874E; Monark Exercise AB, 
Varberg, Sweden). The test is a simple one that is carried out at 
70-72 R.P.M. against a workload of 1.4kg (100 watts) for a total of
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six minutes. We measured blood pressure after 90 seconds and 
every two-minutes till completion, heart rate was recorded every 
sixty seconds.
Maximal Exercise Test (C hapters 3 -5 )
All maximal exercise tests were carried out on an upright stationary 
cycle ergometer (874E; Monark Exercise AB, Varberg, Sweden) 
using a standardised protocol. After two minutes of rest, the 
subject began to cycle at 60 R.P.M. against a workload of 1kg (60 
Watts), after three minutes the workload was increased to 1.3kg 
and the speed to 70 R.P.M. (90 Watts) for a further three minutes. 
There were then a further three stages at 120, 150 and 180 Watts 
for three minutes each. This was followed by one-minute stages of 
twenty-watt increments until the subject indicated fatigue. Expired 
gases, blood pressure and heart rate were measured throughout.
Arithm etic Stress Test (C hapter 6 )
We used a widely used and validated mental arithmetic stress test. 
Briefly subjects continuously subtracted the number 7 from a 
random 4-digit number. Subjects answered verbally and were 
encouraged by an investigator to subtract as fast as possible. When 
subjects paused for more than 2 seconds or answered incorrectly 
they were given the correct answer and pressed to improve their 
performance.
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Reproducibility and R eliability studies
The equipment we used has been shown to be accurate and 
reproducible within our group and others, but to confirm our 
confidence in the equipment that we were using we carried out a 
small reproducibility study.
Prior to the start of our studies, we carried out repeatability studies 
on arterial function and haemodynamics at baseline, during exercise 
and post maximal exercise. We chose maximal exercise, as it 
would be the modality with the greatest difficulty to get accurate 
and reproducible measurements. Ten subjects completed baseline 
readings (10 minutes), a maximal exercise test and then a further 
ten minutes of recovery readings. In the table below, we outline 
the reproducibility of the baseline values as an average, the 
exercise readings from three stages (60, 120 and 180 Watts) and 
the first recovery reading.
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Table 2.3 Pulse W ave Velocity and Haemodynamics a t rest, 
during exercise and recovery*
Baseline
A
60
W atts
120
W atts
180
W atts
Recovery
Brachial-Radial 7.3% N/A N/A N/A 9.4%
PWV
Femoral-Tibial 6.8% N/A N/A N/A 8.7%
PWV
Aortic PWV 5.9% N/A N/A N/A 8.4%
Systolic blood 2.8% 3.2% 4.6% 5.4% 3.6%
pressure
Diastolic blood 3% 4% 5.2% 5.8% 3.9%
pressure
Heart Rate 2% 3.4% 4.3% 5.4% 3.6%
Stroke Volume 5% 7% 8% 8.9% 6.8%
Cardiac Output 4.8% 7.6% 9.2% 11.1% 8.4%
♦Coefficient of variation for replicate measures
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Chapter 3
Large A rtery  Responses to  Exercise
The Influence of M odality, In te n s ity  and Duration
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Introduction
Pulse wave velocity is a non-invasive marker of arterial stiffness and 
is related to mortality and morbidity in health and disease37, 38,108, 
like other measures of arterial stiffness. It  has been well 
established that increases in arterial stiffness cause increases in 
resting7 and exercising blood pressure185. Individuals who carry out 
regular aerobic exercise have a reduced risk of mortality and 
morbidity from cardiovascular disease3 and recent studies have 
shown that athletes have markedly higher arterial compliance and 
distensibility120 when compared to age matched controls and that 
sedentary subjects who undertake short term (8-12 weeks) exercise 
training show increased distensibility independent of changes in 
resting blood pressure125. There have been few studies that have 
assessed acute arterial stiffness changes during and soon after 
exercise. These studies have in general shown a decrease in 
stiffness of the exercising limb that lasts for up to an hour. 
However these studies have generally looked at an individual artery 
and have used exercise of different modalities, intensities and 
durations in addition to the different methods of assessing arterial 
stiffness. Below we give a brief outline of these studies.
In the mid 1950's Simonsen and colleagues looked at aortic PWV 
pre and post-moderate treadmill exercise (3 m.p.h and 5%  
gradient), and reported no change in pulse transmission following
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exercise136. More recently Naka et al demonstrated that after a 
maximal exercise test to volitional exhaustion, subjects who were 
free of cardiovascular disease showed a marked reduction in 
femoral PWV137. This reduction lasted for up to an hour and 
indicates a persistent increase in arterial distensibility in the 
exercising limb following acute maximal exercise. Also Kingwell and 
colleagues demonstrated that half an hour after a single bout of 
cycle exercise that aortic and femoral arterial compliance was 
increased138. In a recent study Suguwara et al have shown that 
acute single leg cycling at a very low intensity (20-30 watts for 5 
minutes) reduces femoral PWV in the exercising but not in the 
contra lateral non-exercising limb140.
The aim of this initial project was to evaluate whether exercise of 
different natures would reduce PWV similarly. During these studies 
we assessed where possible the responses in the exercising and 
non-exercising limb. We assessed the response into three forms of 
exercise. These sections would evaluate 1) aerobic, 2) resistance 
and 3) isometric exercise.
1: We recruited 20 men to a study that accessed 6 different
exercise intensities. All exercise studies were carried out on a cycle 
ergometer.
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2: Resistance exercise of a chronic nature has been shown to
increase arterial stiffness and cardiovascular disease. Recent 
studies have shown that there may be no difference between a 
resistance trained subjects arterial responses to exercise and a 
sedentary non-resistance trained control. To our knowledge no one 
has assessed the arterial response to acute resistance exercise in 
non-resistance trained subjects. Subjects completed four different 
resistance exercise bouts on different limbs to assess local and 
systemic responses.
3: Isometric exercise provokes rapid responses in blood pressure
far greater than the oxygen consumption increase of such work and 
without the changes in blood flow to the exercising leg. We carried 
out a study to assess whether isometric plantar flexion would 
reduce similar decreases in FTPWV and BRPWV as seen in aerobic 
exercise studies.
Methods 
Recordings
Heart rate was recorded on a minute-by-minute basis at rest, 
during exercise and in recovery using a standard electrocardiogram. 
Femoro-Tibial and Bracho-Radial Pulse Wave Velocity were recorded 
for ten minutes at baseline and in recovery. Blood pressure was 
recorded every two minutes during rest and recovery and at various
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time intervals during the exercise tests, ranging from every minute 
to every ten minutes. In all studies, subjects completed a 
familiarisation visit in which the exercise tests, arterial recordings 
and protocols were explained and subjects had any queries 
answered.
Study 1 -  Aerobic Exercise (N = 2 0 )
The subject then returned for an initial study to assess their 
maximal exercise capacity. Following this study the subjects were 
randomly allocated a number by a member of staff not involved in 
the study. This decided the order that the subjects completed the 
exercise protocol in. The six protocols were A) 15 minutes at 25%  
of V02max, B) 45 minutes at 25% of V02max, C) 15 minutes at 
50% of V02max, D) 30 minutes at 50% of V02max, E) 15 minutes 
at 75% of V02max and F) maximal exercise test. Before each test, 
a fifteen-minute relaxation period was undertaken and then baseline 
measures were completed. The subject then completed the 
required exercise protocol; on cessation of exercise the subject had 
all baseline measures repeated over a ten-minute period. All 
studies were completed at least 72 hours apart and within a four 
week period.
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Study 2 -  Resistance Exercise (N = 1 0 )
All subjects completed maximal strength tests as outlined in chapter 
two. Briefly, single arm bicep curl and leg extension exercises were 
completed to assess maximal quadriceps and bicep strength 
capacity. The subjects then carried out four studies in a 
randomised order. The studies consisted of baseline, exercise and 
recovery measurements. The exercise was six minutes of muscular 
contractions on a single muscle bed at 40%  of the maximal strength 
tests. Before each test, a fifteen-minute relaxation period was 
undertaken and then baseline measures were completed. The 
subject then completed the required exercise protocol; on cessation 
of exercise the subject had all baseline measures repeated over a 
ten-minute period. All studies were completed at least 72 hours 
apart and within a four week period.
Study 3 -  Isom etric  Exercise (N = 1 0 )
On arrival the patient completed a maximal plantar flexion protocol 
as detailed in chapter 2. Following maximal plantar flexion a 
fifteen-minute relaxation period was undertaken and then baseline 
measures were completed. The subject then completed the 
required exercise protocol (Either 20, 40 or 60% of MVC for two 
minutes); on cessation of exercise the subject had all baseline 
measures repeated over a ten-minute period. All studies were 
completed at least 72 hours apart and within a four week period.
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Statistical Analysis
For all studies the baseline data is presented as the mean of ten 
minutes, exercise data is presented as the mean of each study, 
unless otherwise noted, while recovery is presented as early, middle 
or late, which represents minutes 1-3, 4-6 and 7-10 respectively. 
The data is presented as the mean plus or minus the standard 
deviation of the mean. All comparisons were completed using 
repeated measures analysis of variance with post-hoc analysis 
completed with a significance value set at P<0.05.
Results
Table 3.1 Patient Characteristics
Age H eight W eight B M I SBP DBP
(years) (m ) (k g ) ( k g /m 2 ) (m m H g ) (m m H g )
Study 1 26.4 1.76 73.6 22.9 119 77
(n=20) (0.9) (0.03) (2.1) (1.1) (3) (2)
Study 2 27.3 1.77 75.4 24.0 123 80
(n=10) (1.1) (0.04) (1.8) (0.7) (3) (2)
Study 3 26.8 1.74 74.2 24.5 119 81
(n=10) (0 .8 ) ... iO :05).. (2.2) (0.9) _ (3) (3)
There were no significant differences between baseline arterial and 
haemodynamic measures on any day of the studies (P=NS).
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Study 1 
Haemodynamics
All haemodynamlc variables increased from baseline to exercise 
(P<0.05) with the exception of diastolic blood pressure which was 
slightly, but not significantly (P=NS), lower with the low intensity 
exercise (25-50% of V02max) and significantly lower during 
maximal and high intensity exercise (75% V02m ax) (P<0.05).
Table 3 .2  Haem odynam ic Responses to  Aerobic Exercise
In tensity Duration SBP DBP PP HR
(% ) (M ins) (m m H g) (m m H g ) (m m H g) (B ts /m in )
25 15 137 (8) * 65 (6) 72 (7) * 102 (9) *
25 45 135 (1) * 60 (3) 75 (5) * 103 (10) *
50 15 168 (5) * 67 (6) 101 (6) * 136 (9) *
50 30 172 (6) * 65 (7) 108 (6) * 142 (8) *
75 15 194 (7) * 65 (4) * 129 (7) * 174 (10) *
100 Varied 224 (8) * 62 (7) * 162 (8) * 191 (9) *
*  = Different to baseline (P<0.05)
Pulse W ave Velocity
The femoral and brachial artery responses to exercise are presented 
in Figure 3.1 (a-d). There were no significant differences between 
baseline values for either femoral or brachial PWV (Table 3.3, 
P=NS) and exercise data is therefore presented as both the 
absolute changes (a) and (c) and the percentage change from 
baseline (b) and (d). There was no significant change in brachial 
PWV following sub-maximal exercise of any intensity, but maximal 
exercise resulted in a significant fall throughout the recovery period
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(P<0.05). This was presumably due to the increase in upper-body 
work during maximal or supra-maximal exercise, converting the 
arms from being a non-exercising bed into an exercising bed. The 
three lowest levels of exercise (25-15, 25-45 and 50-15) resulted in 
no change in femoral PWV (P=NS), while the three higher 
intensities demonstrated significant decreases post exercise and 
through recovery (P<0.05).
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Figure 3.1 (a+ b ) Absolute and Relative changes in 
Femoral Pulse Wave Velocity following sub and maximal 
cycle ergometry
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The three lowest levels of exercise (25-15, 25-45 and 50-15) 
resulted in no change in femoral PWV (P=NS), while the three 
higher intensities demonstrated significant decreases post exercise 
and through recovery (P<0.05).
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Figure 3.1 (c+ d ) Absolute and relative changes in 
Brachial Pulse Wave Velocity following sub and m axim al 
cycle ergometry
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There is no significant change in brachial PWV following sub- 
maximal exercise of any intensity, but maximal exercise has 
resulted in a significant fall throughout recovery (P<0.05).
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Table 3.3 Baseline brachial and fem oral Pulse W ave Velocity
Study Brachial PWV Femoral PWV
(m /s )_______________(m /s )
25-15 4.7 (0.4) 7.4 (0.6)
25-45 5.0 (0.6) 7.9 (0.6)
50-15 5.1 (0.3) 7.5 (0.7)
50-30 4.6 (0.5) 7.0 (0.5)
75-15 5.0 (0.5) 7.0 (0.6)
Maximal 4.7 (0.2) 6.9 (0.4)
P=NS for all studies
Study 2 
Haemodynamics
As shown in table 3.4 all the variables increased from baseline 
(P<0.05) apart from DBP, which showed a moderate non-significant 
decrease (P=NS). The systolic pressure and heart rate were 
significantly higher during leg exercise when compared to the 
values obtained during arm exercise (P<0.05). This is presumably 
due to the significantly larger muscle mass and therefore oxygen 
consumption of the lower limb.
Table 3 .4  Haem odynam ic Responses to  Resistance Exercise
Exercising SBP DBP PP HR
Limb (m m H g) (m m H g ) (m m H g) (B ts /m in )
Baseline
Right Arm 122 (7) 80 (5) 42 (3) 74 (6)
Left Arm 119 (8) 81 (6) 38 (4) 77 (7)
Right Leg 116 (7) 76 (8) 40 (3) 74 (8)
Left Leg 121 (9) 78 (7) 43 (3) 72 (6)
Exercise
Right Arm 166 (9) * 70 (6) 96 (5) * 122 (9) *
Left Arm 168 (10) * 68 (5) 100 (9) * 120 (5) *
Right Leg 182 (12) *  ! 74 (5) 108 (8) *  ! 136 (7) *  !
Left Leg 180 (12) *  ! 72 (6) 108 (7) *  ! 140 (6) *  !
* = Significantly different from baseline (P<0.05)/ ! = Significantly different from
arm (P<0.05)
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Pulse W ave Velocity
Following exercise the first reading of PWV was completed within 
two minutes. The graph below (Fig 3.2) demonstrates baseline and 
immediate post exercise values fo r all of the limbs during each 
study. All pulse wave velocities had returned to baseline within 3 
minutes of cessation of exercise and therefore only immediate 
recovery is presented.
Fig 3.2 Pulse W ave Velocity following resistance
exercise
9 
8 
7 
6
PWV 
(m/s) 4
3
2
1
0
LA - LA - LA - LA - RA - RA - RA - RA - LL - LL - LL - LL - RL - RL - RL - RL - 
LA RA LL RL LA RA LL RL LA RA LL RL LA RA LL RL
First Letters (E.g. LA) is studied limb second letters (E.g. RA) equals 
exercised limb. RA = Right arm , LA = Left arm, RL = Right leg, LL = Left 
leg *  = D ifferent from  baseline (P < 0 .0 5 )
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Study 3 
Haemodynamics
Table 3.5 shows that there is a marked pressor and chronotropic 
response to isometric exercise, with the heart rate and blood 
pressure being significantly different from baseline and increasing 
with each exercise intensity.
Table 3.5 Haem odynam ic responses to  acute isom etric  
plantar flexion
BP Base BP Ex BP Rec HR Base HR Ex HR Rec
20% 116/68 138/66 * 122/71 65 87 * 71
(8/4) (8 /5) (5 /6 ) (8) (9) (8)
40% 119/64 144/69 *  ! 130/72 67 94 *  ! 72
(7/4) (10 /8) (6 /4 ) (11) (10) (7)
60% 121/64 153/74 *  ! 138/71 63 99 *  ! 72
(7/6) . ( U /6 ) (7 /4 ) , - (9), (12) .....1 2 ) .....
*=  Different to baseline ! = Different to previous exercise intensity
All exercise systolic blood pressures and heart rates are significantly 
higher than baseline, and each value at each exercise intensity, is 
significantly greater than the previous intensity (P<0.05). Diastolic 
blood pressure only shows significant increases from baseline and 
between exercise at 60% (P<0.05).
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Figure 3.3 Pulse W ave Velocity following isometric exercise of 
increasing intensity
7.0
6.0
FPWV 
(m/s)
5.0
4.0
3.0
* = D iffe re ^ S m lsmPS><T) ^ se,ine B,ack Columns = Recovery 
Pulse W ave Velocity
As shown in figure 3.3 there was a significant reduction in Femoral 
Pulse Wave Velocity following isometric exercise (Average of 2 
minutes readings) (P<0.05), there were no significant differences 
between baseline readings. The Bracho-Radial PWV did not change 
(P=NS).
Percentage of Maximal Voluntary Contraction
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Discussion
Study 1
No significant change in brachial PWV was observed following sub- 
maximal exercise of any intensity, but maximal exercise resulted in 
a significant fall throughout recovery (P<0.05). This is presumably 
due to the increase in upper-body work during maximal or supra­
maximal exercise186, converting the arms from being a non­
exercising bed into an exercising bed. In contrast, and except 
following minor levels of exercise, a sustained reduction in femoral 
PWV was observed following both submaximal and maximal 
exercise.
The most likely explanation for this increase in large artery 
distensibility is a significant increase in release and/or formation of 
a local metabolite from the vascular endothelium (e.g. Nitric Oxide, 
Prostaglandins), or from the exercising muscle (Lactate, Potassium, 
adenosine), although a neural mechanism is also possible. The 
vascular endothelium is a barrier between the blood and the 
vascular smooth muscle and the endothelium actively modulates 
vascular smooth muscle tone via release of NO, prostaglandins and 
endothelial derived relaxation factors65, 187, 188. NO activates 
guanylate cyclase to increase cyclic guanosine monophosphate 
(cGMP) and this causes vasorelaxation. At rest, low levels of NO
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are continuously synthesised and released generating a constant 
counter against sympathetic vasoconstriction.
Shear stress is the result of the frictional force applied to the 
endothelium by blood flow though a vessel. This can increase in 
one of two ways 1) a decrease in vessel diameter (vasoconstriction) 
without a decrease in flow, 2) or as an increase in blood flow 
without an increase in vessel diameter. Shear stress has been 
shown to potentiate agonist-stimulated NO release66,68, and chronic 
shear stress (exercise training) up regulates type I I I  NOS 
expression81,82,189,19°. Unlike the other forms of NOS, type I I I  NOS 
is membrane bound, this positioning of type I I I  NOS appears to 
enable NO synthesis to be regulated by shear stress191 
(Transduction mechanisms sheer related NO release mediated by 
the kinase AKT)
Prostaglandins (PG's) belong to the family of prostanoids and are 
produced mainly from arachadonic acid by the enzyme 
cyclooxygenase. PGs are known to modulate platelet aggregation 
and inflammation and oedema. PG's also modulate tissue blood 
flow at rest and during increases in metabolic demand such as 
exercise and reactive hyperaemia192. Their role in regulating the 
large increases in muscle blood flow during exercise has not been 
clearly demonstrated, but this may be because there are multiple
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redundant mechanisms193. Several interactions are known to exist 
between specific vasodilator substances, and therefore PGs can act 
in synergy with other substances and contribute to functional 
hyperaemia. Furthermore, there is evidence for differential, tissue- 
specific influences of PGs where their influence on blood flow during 
exercise may be profound. PG's have been shown to exhibit a role 
in the exercise hyperaemia in both human and animal models, with 
the magnitude of the response varying with the technique involved 
(Doppler ultrasound versus plethysmography) and the route of 
administration (local or systemic)194.
Study 2
Sub-maximal resistance exercise was associated with an immediate 
post exercise reduction in the PWV of the exercising limb, implying 
an increase in the arterial distensibility. This may be a consequence 
of the increase in flow to the exercising limb. Exercising limb blood 
flow increases markedly in association with a large fall in local 
vascular resistance, due to local metabolic stimuli. Local skeletal 
muscle metabolic factors cannot of course be immediately 
responsible for the increase in large artery distensibility, because 
these vessels are upstream.
Although these factors have yet to be fully elucidated, local 
vasodilator mechanisms involving the muscle vascular endothelium
n o
and limited retrograde travel of dilator signals have been 
postulated195. Once local intramuscular vasodilatation has occurred 
then flow in the femoral artery will increase and therefore cyclic wall 
stress on its endothelium will follow. This is a well-known 
vasodilator stimulus, which would facilitate the increased muscle 
blood flow. Therefore the observed increase, in distensibility 
immediately post exercise, could be attributed to endothelium 
dependent vasodilation. An alternative idea to explain post exercise 
increases in arterial distensibility is that an exercise driven increase 
in sympathetic vasoconstrictor tone is decreased at this time
Certainly systemic sympathoexcitation caused by muscle 
metaboreflex activation during the handgrip and calf exercise would 
be expected to oppose vasodilatation during exercise 52, 53, 58, 196. 
However, rapid wash out of the metabolites on cessation of exercise 
removes this reflex response and sympathetic activity quickly 
returns to baseline, as is supported by the rapid recovery of BP in 
the control experiments. In addition the fact that there was no 
change in the non-exercising limbs suggest that a local factor must 
be involved.
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Study 3
Consistent with previous observations of isometric exercise there 
was a marked pressor response and moderate rise in heart rate, 
which increases with increasing intensity197. This is the first study 
that we are aware of that demonstrates that isometric exercise, 
even in the face of a marked pressor and chronotropic response, 
augments arterial distensibility in the exercising limb.
Conclusions
Acute exercise of a significant intensity leads to increases in arterial 
distensibility, primarily in the exercising limb, even in the presence 
of a marked pressor and chronotropic response. As study 1 and 2 
show the change is predominantly in the exercising limb and 
following aerobic exercise last for at least ten minutes. This may be 
an indication of a local response overriding any systemic 
sympathetic response, however this will require further 
investigation.
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Chapter 4
The Exaggerated Systolic Blood Pressure Response to  
Exercise in Health and Disease
The role o f th e  conduit arteries
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Introduction
As discussed in the introduction and previous chapter, studies have 
shown that acute and chronic exercise can improve arterial 
distensibility. This may be an important factor in the control of 
blood pressure, particularly systolic pressure, on exercise. In 
otherwise healthy individuals an exaggerated Systolic Blood 
Pressure (ExSBP) response to exercise is a marker of increased risk 
for cardiovascular disease, including stroke and myocardial 
infarction27'29,34,35. However what is not clear from these studies 
was the risk factor status of these subjects and whether they had 
normal arterial function at rest. Below we summarise the data from 
a few of these studies and outline the reason for this study.
Normotensive subjects with an ExSBP have been shown to be at 
increased risk of developing future essential hypertension (ESH), 
Isolated Systolic Hypertension (ISH) and suffer a greater risk of 
future stroke and myocardial infarction27"29,34,35. However, it is not 
always clear whether this is because such patients have other 
cardiovascular risk factors or whether ExSBP can occur in the 
absence of other conventional cardiovascular risk factors. Recently 
Stewart et al demonstrated that subjects with an ExSBP 
demonstrate a high resting PWV and an impaired flow-mediated 
dilatation of the brachial artery198. This backs up the data from the 
Dundee group in which subjects with an ExSBP showed an
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impairment of NO dependent forearm vasodilation compared with a 
group of controls with a normal blood pressure response199.
The literature regarding exercise and PWV is very scarce with most 
studies looking at subjects whom have exercised chronically 
(athletes) versus their sedentary counterparts. These studies have 
shown that in older athletes (>20 years) there is a significant 
reduction in aortic and peripheral PWV in the athletic population120. 
The few studies that have looked at acute exercise and its effects on 
PWV have looked at exercise of a very low intensity, which showed 
no change, or exercise of a moderate intensity which resulted in a 
decrease in PWV thirty minutes into recovery138. More recently 
Naka et al have shown that healthy subjects who complete a 
maximal treadmill test to volitional exhaustion exhibit a marked 
reduction in femoral PWV, which persists for an hour post 
exercise137. We have also shown in chapter 3 that single limb 
exercise using continuous rhythmical exercise results in a reduction 
in the exercising limb PWV without any subsequent change to the 
other non-exercising arterial beds. Pathologically we know that 
subjects with an ExSBP suffer a greater rate of stroke, myocardial 
infarction and hypertension. Subjects with hypertension and heart 
failure have increased PWV compared to healthy controls.
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In chapter three we have shown that subjects with a normal blood 
pressure response to exercise and no cardiovascular risk factors 
acutely improve arterial distensibility immediately after assessed 
maximal and sub-maximal exercise. However we have studied 
relatively small groups (10-20 subjects) and the subjects were 
mainly young, and were totally free of cardiovascular risk factors, so 
we cannot draw any conclusions as to whether this would be normal 
for the population.
In this study we recruited two separate groups into two separate 
studies. Study 1 aimed to define the prevalence of an ExSBP in 
healthy subjects without risk factors during two submaxima I tests 
that have been used in previous studies of ExSBP, the Dundee step 
test and the 100-Watt Cycle test. The second part of study 1 was 
to determine the resting, exercise and recovery haemodynamics 
and arterial function in this group. We recruited 100 consecutive 
visitors to an open access risk factor clinic, who had been found to 
be free of conventional risk factors and consented to the two study 
visits.
Study 2 aimed to assess prevalence of ExSBP during the Dundee 
Step Test in patients with borderline cardiovascular risk factors and 
to assess the arterial responses to controlled sub-maximal exercise.
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Methods
Subject Recruitment
Study 1: We recruited from an Open Access Risk Factor clinic at the 
Wales Heart Research Institute. All subjects were male, aged 
between 18 and 50, normotensive (< 130/90), had normal 
cholesterol (<5.2, mmol/dl), were non-smokers, were free of 
diabetes and not taking cardiovascular medication. They also had 
to consent to the both arms of the study. There were 723 visitors 
to the clinic before our recruitment was complete.
Study 2: We recruited 20 males from the same Open Access Risk 
Factor clinic, however subjects included had borderline hypertension 
(130-140/80-90 mmHg) and/or mildly elevated cholesterol (5.2- 
6.0, mmol/dl), but were free of diabetes, non-smokers and on no 
cardiovascular medication.
Measurements
Heart rate was recorded on a minute-by-minute basis at rest, 
during exercise and in recovery using a standard electrocardiogram. 
Femoro-Tibial and Bracho-Radial Pulse Wave Velocity were recorded 
for ten minutes at baseline and in recovery. Blood pressure was 
recorded every two minutes during rest and recovery and at various 
time intervals during the exercise tests, ranging from every minute
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to every ten minutes. In all studies, subjects completed a 
familiarisation visit in which the exercise tests, arterial recordings 
and protocols were explained and subjects had any queries 
answered.
Study 1 (a ) -  Haem odynam ic responses to  sub-m axim al 
exercise (N = 1 0 0 ) (No risk-factor group)
Following positioning of the sphygmomanometer and 
electrocardiogram subjects rested for fifteen minutes. A ten- 
minute baseline reading was completed, before the subject 
completed the Dundee Step Test. After a further 45 minutes of 
recovery baseline readings were re-measured and then the 100- 
Watt cycle test was completed.
Study 1 (b ) -  Haemodynamic and arteria l responses to  
maximal exercise (N = 1 0 0 ) (N o risk-factor group)
Subjects had the sphygmomanometer, Scimed system and 
electrocardiogram positioned and rested for fifteen minutes. A ten- 
minute baseline reading was completed, before the subject 
completed a maximal exercise test on a cycle ergometer. On 
cessation of exercise the subject returned to the supine position for 
ten minutes of recovery readings (The first recovery reading was 
always complete within 2 minutes of exercise cessation).
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Study 2 (a ) -  Haem odynam ic responses to  Dundee Step tes t 
(N = 2 0 )
Subjects had the sphygmomanometer and electrocardiogram 
positioned and then rested for fifteen minutes. A ten-minute 
baseline reading was undertaken, before the subject completed the 
Dundee Step Test. The results of this test used to divide the group 
into ExSBP (SBP >180 mmHg during test) or Normal Systolic Blood 
Pressure (NSBP) (SBP <180 mmHg during test).
Study 2 (b ) -  A rterial responses to  sub-m axim al exercise  
(N = 2 0 )
Subjects had the sphygmomanometer, Scimed system and 
electrocardiogram positioned and then rested for fifteen minutes. 
A ten-minute baseline reading was completed, before the subject 
completed 15 minutes of walking at 75% of age predicted maximal 
heart rate ((220-age)*0.75). On cessation of exercise the subject 
returned to the supine position for ten minutes of recovery readings 
(The first recovery reading was always complete within 2 minutes of 
exercise cessation).
Statistical Analysis
For all studies the baseline data is presented as the mean of ten 
minutes, exercise data is presented as the mean of each study, 
unless otherwise noted, while recovery is presented as early, middle
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or late, which represents minutes 1-3, 4-6 and 7-10 respectively. 
The data is presented as the mean plus or minus the standard 
deviation of the mean. All comparisons were completed using 
repeated measures analysis of variance with post-hoc analysis 
completed with a significance value set at P<0.05.
Results 
Study 1 (No risk-factor group) 
Subject Data
The mean data is presented for the 100 male subjects who were 
free of all risk factors in Table 4.1
Table 4.1 Subject's Characteristics
Age Height W eight BM1 SBP DBP
(Years) (m ) (kg ) (K g /m 2) (m m H g) (m m H g )
Mean 38 1.75 74.5 24.3 124 82
(SD) (8) (0.09) (4.8) (2.5) .........(9) ... (8).....
Dundee Step Test and 10 0 -W att Cycle Test
For both tests we employed the definition of an ExSBP which had 
previously been shown to be associated with an increase risk of 
development of resting hypertension, myocardial infarction and 
stroke or had demonstrated an abnormal arterial function in this 
patient group i.e. > 180 mmHg during the Dundee Step Test, or > 
200 mmHg after 6 minutes of cycling at 100 watts. In the Dundee 
step test the mean systolic pressure at end of test was 162 (11)
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mmHg with a mean heart rate of 108 (11) BPM. During the 100- 
Watt Cycle Test the mean systolic blood pressure following six 
minutes was 166 (8) mmHg with a heart rate of 114 (13) BPM. 
None of our subjects had an SBP in excess of 180 or 200 mmHg at 
the end each respective test and neither test resulted in a 
significantly greater pressor or chronotropic response than the other 
(P=NS between tests). Table 4.2 tabulates the baseline and 
exercise responses for each study.
Table 4 .2  Haemodynamics a t rest and during sub-m axim al 
exercise
Heart Rate SBP DBP PP
(B ts /m in ) (m m H g) (m m H g) (m m H g )
Baseline 1 73 (7) 123 (7) 81 (8) 42 (7)
Dundee 108 (11)* 162 (11 )* 78 (8) 84 (8 )*
Baseline 2 70 (6) 119 (8) 80 (7) 39 (6)
100-Watt 114 (13)* 166 (8 )* 76 (10) 90 (10 )*
* = Different from baseline
Arterial and Haemodynamic Responses to  M axim al Exercise
Heart rate and SBP rose from baseline and through each stage of 
testing (P<0.05 for all), the diastolic blood pressure fell (P<0.05 for 
group baseline vs. group max BDP). Baseline femoral and brachial 
pulse wave velocity was 7.1 (0.6) and 4.7 (0.8) m/s and fell 
following maximal exercise and was lower throughout recovery 
(P<0.05 compared to baseline). Figures 4.1 and 4.2 depict these 
results.
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Fig 4.1  
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Study 2 
Subject Data
Subject's physical characteristics are presented in table 4.3 there 
were three significant differences between the NSBP ( n = l l )  and the 
EXSBP (n=9) groups; these were weight, BMI and cholesterol 
(P<0.05). The study 2 group as a whole were younger, heavier and 
with higher systolic blood pressure and Cholesterol, values.
Relationship of Arterial Changes to  Physiological 
Characteristics
Of note although the data has not been displayed was that there 
was no relationship between change in PWV or augmentation as 
such when compared to any resting or exercise blood pressure, 
exercise capacity or baseline characteristics (height, weight etc).
Table 4 .3  Subjects Physical Characteristics
Age
(Years)
Weight
(Kg)
Height
(m )
BMI
(Kg/m 2)
Rest
S.B.P.
(mmHg)
Rest
D.B.P.
(mmHg)
Choi
(mmol)
All 30 78 1.75 25.4 128 79 5.4
(6) (8) (7) (2.3) (11) (8) (0.8)
NSBP 29 74 1.76 24.5 126 80 4.7
(4) (7) (8) (2.0) (6) (8) (0.6)
EXSBP 31 81 1.74 26.2 130 78 5.7
(3) (9) (6) (1.9) (9) (7) (0.7)
_ § 1 9 ..... P=NS P<0.05 P=NS P <0.05 P=NS P=NS P<0.05
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Dundee Step Test
As discussed the subjects were split into NSBP and ExSBP 
depending on the SBP response to the Dundee step test, figure 4.3 
shows the different SBP response during stepping for NSBP and 
ExSBP. There were no significant differences in diastolic blood 
pressure (P=NS) but pulse pressure, mean blood pressure and 
heart rate were higher in ExSBP than in NSBP (P<0.05 for all).
Haemodynamic responses to controlled sub-m axim al 
exercise
The subjects completed fifteen minutes of treadmill walking at a 
pace that resulted in the subjects walking with the speed and incline 
adjusted so that each individual walked at 75% of APMHR for 15 
minutes. ExSBP had a significantly higher SBP during treadmill 
walking when compared with NSBP (197 (16) V 172 (19) mmHg, 
P<0.05), see figure 4.4.
Figure 4.3  NSBP and ExSBP systolic pressure response to  
Dundee Step Test
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Figure 4 .4  NSBP and ExSBP heart rate and systolic pressure 
response to sub-m axim al treadm ill exercise (7 5 %  
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Arterial Responses to  controlled sub-m axim al exercise
Baseline Femoral Pulse Wave Velocity was not different between 
ExSBP and NSBP (7.5 V 7.2 m/s, P=NS). Following exercise FPWV 
was significantly reduced in NSBP and remained so for the recovery 
period (Early, mid and late (6.0, 6.3 and 6.6 m/s, P<0.05 to 
baseline). In contrast, the ExSBP showed no fall in FPWV, and 
therefore no increase in distensibility, and PWV was never 
significantly lower than baseline (Early, mid and late (7.1, 7.3 and 
7.3 m/s, P=NS to baseline). The ExSBP group had a significantly 
higher FPWV during recovery when compared with NSBP for all time 
points Fig 4.4 (P<0.05).
Discussion
An Exaggerated Systolic Blood Pressure (ExSBP) response to 
exercise was not found in a consecutive series of 100 healthy males 
without cardiovascular risk factors, using either the Dundee step 
test or the 100-Watt cycle test. All subjects completed the Step 
test and cycle test with SBP < 180 and 200 mmHg respectively. 
Baseline arterial function was normal and all subjects showed a 
reduction in conduit pulse wave velocity (Brachial and Femoral) 
following maximal cycle exercise. Of note, no subject had a peak 
systolic blood pressure of greater than 230 mmHg, a marker of 
exaggerated blood pressure during maximal stress. This finding 
infers that subjects who are free of cardiovascular risk factors,
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including smoking, diabetes, hypertension, and abnormal lipids are 
able to augment their arterial distensibility on exercise and this may 
maintain a normal blood pressure response.
When subjects with borderline hypertension and/or cholesterol were 
exercised according to the Dundee step test, 45% had an ExSBP as 
defined as >180 mmHg. The difference between the two groups is 
only partly explained by physical fitness as the difference in systolic 
blood pressure between NSBP and ExSBP remained, if slightly 
blunted, when exercise intensity was controlled. As the groups had 
similar resting blood pressure and arterial function it was interesting 
to note that whilst the group with borderline risk factors and an 
NSBP were able to augment their arterial distensibility as shown by 
a significant fall in FPWV, the group with ExSBP were unable to 
augment distensibility in the exercising limb. This inability to 
increase arterial distensibility may be the mechanism behind the 
ExSBP and as Lim et al showed an ExSBP group have resting 
endothelial dysfunction, raising the possibility that endothelial 
function may be an important factor. Finally the resting FPWV and 
BP were similar in both groups which results in difficulties in 
identifying which patients are at risk of ExSBP and therefore CHD 
and those that are not from simple resting measures of 
haemodynamics or arterial function such as peripheral pulse wave 
velocity.
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Pathophysiology of ExSBP
Although sparse there is some data assessing physiological 
responses in groups with ExSBP and control. The date is split 
between vascular, cardiac and metabolic function and is discussed 
below.
Vascular function and ExSBP
Stewart and colleagues showed in men (n=38) with untreated high 
normal BP or mild hypertension that the variance in maximal 
exercise SBP and pulse pressure (PP) is due to resting SBP (34 + 
23%, P<0.01) and that flow-mediated dilation (FMD) explained an 
additional 11 and 10% respectively (P<0.01)198. In men FMD was 
the only independent correlate of SBP augmentation (Maximal -  
Resting)(R2 = 0.20, P<0.05). Resting aortic pulse wave velocity 
did not correlate with exercise blood pressure responses. Chang et 
al showed in patients with exercise induced hypertension (n-35) 
that they have impaired endothelial dependent vasodilation, as 
measured by FMD, compared to controls (n=35) (3.14 V's 6.5% , 
P<0.05) and that the systolic difference was significantly correlated 
with the extent of vasodilation (r= -0 .36 , P<0.05)2°°. They also 
measured the concentration of NO2/NO3' and cyclic guanosine 
monophosphate (GMP) at baseline, peak exercise and in recovery 
(30 min post), showing that although NO2 /NO3" increased during 
exercise the rise was the same in both control and patients185.
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However the rise in cyclic GMP was significantly greater in controls 
than ExSBP (8.3 V's 10, pmol/ml, P<0.05), suggesting that the 
increase in ExSBP may be in part due to an inhibition of vasodilation 
via an inadequate increase in cyclic GMP (Fig 4.6). The Dundee 
group have also shown similar findings when they compared ExSBP 
with age matched controls and demonstrated a 150% increase in 
forearm blood flow (FBF) in the control group following acetylcholine 
infusion (100 mmol/min) whilst the ExSBP group demonstrated no 
significant increase (110% , P=NS)201. They also showed that 
complete NO inhibition with high dose L-NMMA (8mmol/kg) 
significantly inhibited FBF in the control group (-44% , P<0.01) 
whilst the ExSBP demonstrated a non-significant drop (-18% , p=ns) 
whilst the differences between the groups were significant 
(P<0.01)199. All of these studies have demonstrated an impairment 
in endothelial derived arterial dilatation, in 1999 Fossum et al 
showed a distinct link between ExSBP and the structure of the 
vascular wall202. In 27 draft recruits whom underwent exercise 
screening, echocardiography, venous occlusion plethysmography 
and biochemical analysis they demonstrated that 19% of the 
variation in blood pressure at the end of six minutes cycling (Mundal 
et a I used this test to determine risk of myocardial infarction) was 
related to minimal forearm vascular resistance (MFVR). MFVR has 
been previously demonstrated to detect peripheral structural
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vascular changes and is the mean arterial pressure divided by the 
maximal forearm blood flow203,204.
Figure 4 .6  NO2 /N O 3" and cyclic GMP in NSBP and ExSBP at 
peak exercise185
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Cardiac function and ExSBP
Many studies have demonstrated that blood pressure responses to 
exercise are related to left ventricular mass, postulating that this 
may be a discreet marker to assess subjects with left ventricular 
hypertrophy26. However until recently no one has looked at cardiac 
function in subjects with an ExSBP. Using standard echo 
measurements Herkenhoff and colleagues showed that subjects 
with ExSBP (n=36) can be split into two groups205. Those with 
normal blood pressure at rest (128/81 mmHg, (n=19) and those
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with raised blood pressure (144/91 mmHg, (n=17) P<0.05 between
groups). Of those with an ExSBP and a raised ambulatory blood
pressure they showed an increase in fractional shortening, a longer
isovolumetric relaxation time and a reduction in the early to late
flow velocity ratio when compared to controls and subjects with an
ExSBP but normal ambulatory pressures (Table 4.4). In all the
subjects with an ExSBP they carried out a "cold pressor" study and
showed that only those whom had raised ambulatory blood pressure
showed an exaggerated pressor response to this stimulus. Thus as
the authors put it "These results support the notion of an integrated
pattern of cardiac and vascular adaptation during the development
of hypertension". They did however demonstrate that none of the
subjects with an ExSBP had LVH on echo or electrocardiogram.
Table 4 .4  Doppler echocardiographic values o f norm otensive  
controls (N T ) and ExSBP w ith  norm al (ExSBP1) or 
elevated (ExSBP2)  am bulatory  blood pressure205
NT (n = 3 6 ) ExSBP1
(n = 1 9 )
ExSBP2
(n = 1 7 )
LVDd (mm) 50.6 ±  2.8 49.5 ±  3 51 ± 2.6
LVMi (g/m 2) 81 ±  9.3 79 ±  12 83 ±  4
PWT (mm) 8.9 ±  0.6 9.0 ±  0.8 9.1 ±  0.7
IVST (mm) 8.9 ±  0.6 9.2 ±  0.8 9.2 ± 0.8
RWT 35 ±  2 37 ±  3 36 ±  4
FS (% ) 40 ±  3 41 ±  4 43 ±  3*
E/A 1.4 ± 0.02 1.3 ±  0.03 1.0 ±  0.02*
IVRT (ms) 79 ±  7 81 ±  4 85 ± 4 *
LVDd = Left ventricular diastolic diam eter LVMi
PWT s Posterior w all thickness IVST
RWT = Relative w all thickness PS
E/A = Early to  late peak flow  ratio  IVRT
* = P<0.05 (ANOVA and Tukey test)
Left ventricular mass index 
In terven tricu lar septal thickne 
Fractional shortening 
Isovolum etric relaxation tim e
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Metabolic function and ExSBP
It has been shown that fasting blood glucose is independently 
associated with resting and exercise blood pressure in healthy 
normotensive, non-diabetic men. Bjornholt et al used a cross- 
sectional and prospective cohort of 2014 healthy middle aged men 
and evaluated resting and exercise blood pressure, intravenous 
glucose tolerance and fasting blood glucose206. After adjusting for 
age, BMI, blood lipids and glucose tolerance, fasting blood glucose 
was strongly associated with exercise (coefficient 6.57, P<0001) 
and resting blood pressure (coefficient 2.83, P<0.0005). It  also 
predicted future development of treated hypertension or elevated 
blood pressure (Odds ratio 1.17, Cl 1.05-1.31) seven years post 
baseline screening. As we demonstrated above the Framingham 
study found no relationship between Exaggerated Systolic Blood 
Pressure during exercise, however they did discover a link between 
exercise diastolic blood pressure and future hypertension207. Brett 
et al showed that diastolic pressure changes during cycle ergometry 
exercise (50,75 and 100 watts) are positively correlated with serum 
cholesterol (R>0.47, P<0.0001 for each workload) and insulin 
resistance (R>0.38, P<0.01, for each workload) in healthy active 
men208. They also showed that in subjects with type I I  diabetes the 
rise in DBP was greater than in control (13.6 mmHg vs. 2.7 mmHg, 
P<0.005).
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Although this data demonstrates that subjects with an ExSBP 
appear to show an inhibition of endothelial derived relaxation 
factors, and certain cardiac abnormalities, it must be remembered 
that all of these mechanistic studies were carried out at rest 
(Excluding the cGMP and NO2" /N O 3 ' data), which may have little 
relevance to what we see during exercise. We believe that our 
study demonstrates for the first time an abnormal arterial response 
immediately post exercise, and probably during, results in an 
ExSBP.
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Chapter Five
Vascular Responses to  Maxim al Exercise
The In flu en ce  o f N itric Oxide
Introduction
Previous work from our group and that of others has shown that in 
healthy subjects there is a reduction in pulse wave velocity of the 
exercising limb/s following, acute and chronic, exercise121,125' 209-211. 
This is true of most modalities of exercise where the intensity is 
sufficient (Chapt 3). The degree of change is directly related to the 
exercise intensity (Chapt 3). Our previous work has also shown 
that it is likely to be a locally mediated mechanism, as the change 
in arterial distensibility is not seen in control arterial beds (Chapt 3). 
We have also demonstrated that an Exaggerated Systolic Blood 
Pressure Response to Exercise (ExSBP) is not present in subjects 
without risk factors (Chapt 4), but is present in those with a number 
of borderline risk factors (Chapt 4). The group with ExSBP failed to 
augment their arterial distensibility following (and presumably 
during) exercise. It  has previously been demonstrated by our group 
that patients with heart failure also fail to augment their arterial 
distensibility in response to exercise (Unpublished finding). Given 
the fact that patients with heart failure, and those with certain 
cardiovascular risk factors, have an impairment of Nitric Oxide 
synthesis and that a magnitude of treatments improve the 
endothelial function and exercise capacity77, 79, 81, 82, 129, 212, 213. 
Tzemos et al showed that subjects with an ExSBP have an impaired 
endothelial response to acetylcholine it is likely that Nitric Oxide 
may play a key role in arterial distensibility during and after
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exercise and therefore the blood pressure response to exercise199. 
We therefore hypothesised that blockade of Nitric Oxide Synthesis 
with NG-monomethyl-L-arginine would blunt the arterial response to 
exercise and that subjects with an NSBP would develop an ExSBP 
and that it may reduce maximal exercise capacity.
As discussed in the introduction, ventriculo-arterial interaction 
markedly influences cardiac performance. Increased arterial 
elastance leads to an increase in ventricular systolic stiffness and 
results in an exaggerated increase in left ventricular end systolic 
pressure on exercise, in turn leading to impaired left ventricular 
relaxation167, 214. This is believed to be a key factor of the 
pathophysiology of heart failure with preserved ejection fraction. 
When we discuss interaction of the arteries and ventricle, it is 
important to note that the primary artery that affects this 
interaction will be the aorta and as yet we have not shown the 
influence that exercise has on this vessel.
The aim of this study was two-fold. First we wished to assess the 
large central arteries, as measured as changes in Aortic PWV and 
augmentation index, response during maximal exercise. Secondly 
we aimed to establish what influence Nitric Oxide has on resting, 
exercise and post-exercise haemodynamics and arterial function. 
To do this we carried out a randomised, double blind, placebo 
controlled, crossover study.
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Methods 
Subject Recruitment
10 male subjects volunteered to participate in this study. None 
smoked, were hypertensive (blood pressure <130/80mmHg), or 
were taking medication (Table 5.2). All subjects gave informed 
written consent and were habituated with the experimental 
procedures, which were approved by the local ethics committee and 
conformed to the Declaration of Helsinki. Subjects were asked to 
refrain from consuming food and caffeine in the eight hours 
preceding the experiments and to have avoided strenuous exercise 
for 48 hours.
Measurements
Beat to beat stroke volume (SV) and HR were measured using a 
non-invasive, bio-impedance monitor and cardiac output (CO) was 
calculated as SV x HR using Task Force® Monitor as has been 
previously described. Blood pressure was measured using an 
aneroid sphygmomanometer as described in the methodology. 
Radial artery pressure waveforms were acquired using applanation 
tonometry (Millar Instruments) and central pressure waveforms 
were generated using pulse wave analysis (Sphygmocor, AltCor 
Medical). Aortic Pulse Wave Velocity was calculated from the carotid 
and femoral waveforms as previously described. BPWV and FPWV 
were measured simultaneously and non-invasively by oscillometry
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(Scimed) as described previously. Due to the complex and sensitive 
nature of arterial measurements we were unable to make 
recordings during exercise and we have tabulated below the 
frequency of each recording (Table 5.1). Please note that the 
quality of the impedance signal was only acceptable for the first five 
stages of exercise and we therefore do not have data for stroke 
volume, cardiac output and total peripheral resistance after 180 
Watts.
Table 5.1 Recordings taken during each stage
Baseline Post-
Infusion
Exercise Recovery
HR, SV, CO Continuous Continuous Continuous Continuous
BP 3 Times 3 Times Every Every 2
stage minutes
PWA and Every 2 Every 2 N/A Every 2
AoPWV minutes minutes minutes
FTPWV Every Every N/A Every Minute
Minute Minute
Calculations
Total peripheral resistance (TPR), an index of the static component 
of arterial load was calculated as mean arterial pressure (dBP + 1/3 
PP) divided by CO. Arterial compliance, an index of the pulsatile 
component of arterial load was calculated as stroke volume divided 
by the pulse pressure. Effective arterial elastance (AE) an index of 
arterial load that incorporates both static and pulsatile components 
was calculated as central end-systolic pressure (obtained from the
138
aortic pressure waveform) divided by SV. All calculations are fully 
described in the methodology.
Protocol
We carried out a randomised, double blind, placebo-controlled, 
crossover trial to assess the impact of Nitric Oxide synthesis 
inhibition on resting, exercise and recovery vascular function and 
haemodynamics. Ail patients carried out a familiarisation visit and 
"practice" maximal exercise test and then returned for two studies. 
Each visit was identical apart from the nature of the infusion. 
Subjects had haemodynamic and arterial assessment equipment 
attached and a 14-gauge venflon was inserted into a forearm vein 
of the left arm. Each trial began with a 15-minute acclimation 
period and was followed by 10 minutes of baseline measurements; 
this was followed by a 5-minute infusion period and 10 minutes of 
post infusion measurements, a maximal exercise stress test and 15 
minutes of recovery readings.
Infusions
A bolus infusion of either the nitric oxide synthase blocker NG- 
monomethyl-L-arginine (L-NMMA) (3mg/kg) mixed with 20ml 
saline, or a saline only solution, was infused over a 5-minute period 
following completion of baseline readings. This was followed by a
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further 50ml infusion of saline with 3 mg/kg/hour L-NMMA, or saline 
only, infused over the remaining study period.
Assessment of N itric Oxide Blockade
To ensure that the dose we had chosen was sufficient to block Nitric 
Oxide synthesis we carried out a randomised trial with three 
separate doses of L-NMMA (6 /12 /18  mg/kg/min) and completed the 
protocol from this study. However we took no arterial or 
haemodynamic measurements but took bloods for analysis of cGMP 
at each stage. There were no significant differences between cGMP 
with any of the doses at any stage of the study (P=ns for all).
Statistical Analysis
All values are expressed as mean plus or minus standard deviation. 
Data is expressed as mean of baseline, post infusion, as stage by 
stage for the exercise protocol and as five-minute averages in 
recovery (Early, Mid Late). Statistical analysis was performed using 
repeated measures ANOVA and post hoc analysis using paired t- 
tests with Bonferroni correction. Significance levels were set at 
P<0.05.
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Results 
Subjects
Subjects were all healthy non-smokers who did not participate in 
regular vigorous exercise and were free from medication, the 
characteristics are tabulated below (Table 5.2). There were no 
significant differences in baseline characteristics between studies 
(P=NS) apart from stroke volume (P<0.05) (Table 5.3, Figure 5.3 + 
5.4).
Table 5.2 Subject Characteristics
Age Height Weight BMI SBP DBP Cholesterol
(years) (m) (kg) (kg /m 2) (mmHg) (mmHg) (m m ol/L)
Mean 30.6 1.77 76.6 24.4 120 74 4.6
SD 5 0.07 9.3 2.7 6 7 1.3
Maximal Exercise Capacity and Haem odynam ics
Before establishing the effects of L-NMMA during sub-maximal 
exercise, it is important to note that any differences in heart rate or 
blood pressure and not due to a change in workload as there was no 
difference in time to peak exercise, maximal exercise capacity, 
anaerobic threshold or Ve/Vco2 slope between saline and vehicle 
(P=NS). As expected in a double-blind study there was no 
significant difference in the effort made as defined by the RER at 
peak exercise (1.18 vs. 1.2, saline vs. LNMMA, P=NS) (Fig 5.1), 
Figure 5.2 also shows that there were no significant differences 
between the maximal pressor or chronotropic response between 
saline and L-NMMA.
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Sub-Maxim al Exercise Haem odynam ics
Table 5.3 Resting, Post Infusion and Sub-M axim al 
Haemodynamics
Baseline PI Stage 1 Stage 2 Stage 3 Stage 4 Stage 5
S SBP 120 (7) 118 (7)! 131 (9) 142 (9) 159 (11) 172 (8) 184 (10)
L SBP 120 (6) 126 (7) 138 (8) 149 (7) 164 (9) 177 (11) 189 (9)
S DBP 74 (5) 73 (6) 69 (6) 67 (7) 64 (7) 65 (9) 64 (8)
L DBP 73 (6) 78 (6) 73 (6) 72 (8) 73 (8) 72 (4) 69 (7)
S MBP 89 (5) 88 (7) 90 (7) 92 (8) 96 (8) 101 (10) 104 (9)
LMBP 89 (4) 94 (6) 95 (6) 98 (9) 103 (9) 107 (9) 109 (8)
S SV 86 (6) ! 86 (6) 89 (4) 95 (4) 92 (4) 91 (4) 101 (4)
L SV 93 (6) 86 (6) 85 (3) 91 (4) 90 (4) 90 (4) 99 (3)
S HR 60 (5) 60 (7)1 91 (8) 104 (10) 121 (10) 139 (11) 155 (13)
L HR 60 (5) 54 (6) 88 (8) 102 (10) 118 (8) 135 (9) 150 (11)
S CO 5.2 (0.7) 5.1 (0.7)! 8.1 (1.2) 9.8 (1.7) 11.1 (1.5) 12.7 (1.8) 15.7 (2.1)
L CO 5.6 (0.6) 4.6 (1.2) 7.5 (1.3) 9.3 (1.4) 10.6 (1.8) 12.1 (1.6) 14.8 (1.9)
S = Saline, L = L-NMMA, SBP = Systolic Blood Pressure (mmHg), DBP = Diastolic 
Blood Pressure (mmHg), SV = Stroke Volume (ml), HR = Heart Rate (Bts/min), 
CO = Cardiac Output (L/min) ! = different to L-NMMA (P<0.05)
Arterial Responses to  M axim al Exercise
As depicted in Figure 5.3 and 5.4
Influence of Nitric Oxide on the  A rteria l Responses to  
Maximal Exercise
As depicted in Figure 5.5 and 5.6
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Fig 5.1 Maximal Exercise Capacity, Anaerobic Threshold, 
VE/V co 2 slope and Respiratory Exchange Ratio 
with and w ithout NO inhibition
ml/kg/min)/
(Vco2/Vo2)
P=NS for all
I | = Saline
= L-NMMA
V02max RER Max V02AT VE/VC02
Fig 5.2 Maximal Haemodynamics w ith  and w ithout NO 
inhibition
240
MmHg/
bts.min
180
120
P=NS for all
| | = Saline
= L-NMMA
SBP DBP
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Fig 5.3 Arterial Load a t rest and post maximal exercise
2 . 5 1-------    — -------------------------------------  — ----------------------   r 20
mmHg/L
mmHg/ml 
and 15 
ml/mm Hg
Early Mid LateBase
Ae (Grey line P=NS for a ll), TPR (Red Line P <0.05  for rec v base), AC 
(Black Line P<0.05 for rec v base)
Fig 5.4 Arterial Stiffness at rest and post m aximal 
exercise
-  o
-107.5
AugPWV
m/s
-206.5
-305.5
-404.5 J
LateMidBase Early
AoPWV (Black Line P<0.05 for rec v base), FPWV (Grey Line P < 0 .05  for 
rec v base ) and A l (Red Line P <0.05  for rec v base)
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Fig 5.5 Arteria l Load a t rest and post m aximal exercise 
influence of L-NMMA
mmHg/ml
mmHg/L
*  = Sig dif from  baseline, ! = Sig dif from  P I and $ = Sig dif between
saline and L-nMMa
A rteria l Elastance
1.6
=L-NMMA
=SALINE
1.4 --1
L2
1
8
Base PI Early Mid Late
Total Peripheral Resistance
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=L-NMMA*$
=SALINE
20
15
»
5
Base PI Early Mid Late
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Arterial Compliance
2.5
=L-NMMA
=S ALINE
2
ml/mmHg
15
1
0.5
MidBase PI Early Late
Fig 5.6 Arterial Stiffness at rest and post m axim al 
exercise influence of L-NMMA
Aortic Pulse W ave Velocity
=L-NMMA
=S ALINE
PWV (m/s)
Mid LatePI EarlyBase
*  = Sig dif from baseline, ! = Sig dif from P I and $ = Sig dif between
saline and L-nMMa
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Femoral Pulse W ave Velocity
9
=L-NMMA
=S ALINE
8
(m/s)
7
6
5
Base PI Early Mid Late
Augmentation Index
=L-NMMA
=S ALINE
Aug (%)
-15
-30
-45
LateMidEarlyBase
*  = Sig dif from  baseline, ! = Sig dif from P I and $ = Sig dif between
saline and L-nMMa
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Discussion
Effects of m axim al exercise on A rteria l Function
Our previous studies showed significant improvements in conduit 
(Femoral and Brachial) arterial distensibility following exercise, 
which is reproduced in the saline arm of this study. We had 
however failed to establish the effects on AoPWV and other central 
markers. All subjects had normal resting arterial measurements, 
which was unaffected by infusion of saline. Following cessation of 
maximal exercise the arterial load as measured by Arterial 
Elastance had not changed from baseline. This is due to the 
significant reduction in total peripheral resistance or static load 
which counter balanced a significant fall in arterial compliance and 
hence maintained the baseline arterial elastance. Following 
cessation of maximal exercise the AoPWV had increased by 0.7 m/s 
(P<0.05 when compared to baseline). However, blood pressure at 
each time point was also significantly different (120/74 vs. 181/57  
respectively, P<0.05). The calculated beta-index, a blood pressure 
independent measure of aortic stiffness215, 216, was not significantly 
different between baseline and any recovery value (32 vs. 28 A.C.U. 
for early recovery, P=NS)). Not withstanding the fact that the Aorta 
has not stiffened following maximal exercise, it has failed to 
augment its distensibility unlike the conduit arteries, which is an 
unexpected finding. When we analyse the arterial data further both
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the peripheral arterial distensibility has increased and the 
augmentation index has fallen.
Effects of N itric Oxide Synthesis Inh ib ition  on Maximal 
Exercise Capacity
As we have shown inhibition of NO with L-NMMA causes endothelial 
dysfunction and caused an increase in arterial stiffness and load at 
rest. This might be expected to result in an arterial and ventricular 
mismatch, impairment in cardiac output with the coupled decrease 
in blood flow with NO inhibition and therefore maximal exercise 
capacity, but we have showed that no performance related measure 
of exercise capacity was affected (time to peak exercise, maximal 
exercise capacity, anaerobic threshold or Ve/Vco2 slope, p=ns for 
all). This was because although the L-NMMA infusion resulted in a 
fall in heart rate, stroke volume and therefore cardiac output at rest 
this was not the case during all levels of sub-maximal, and 
presumably maximal, exercise. Other methodologies that have 
affected endothelial function at rest, such as Methionine loading 
have also failed to affect maximal exercise capacity217.
This may be due to the multiple methods that allow for control of 
vascular smooth muscle. Many studies have blocked adenosine, 
acetylcholine and Nitric Oxide in isolation and reduced exercise 
blood flow but not to the extent expected. In a series of three
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studies by the Minnesota group, coronary flow was measured in 
dogs at rest and during exercise, with inhibition of three possible 
stimuli for increasing flow. The first study showed that infusion of 
glibenclamide, an ATP sensitive K+ channel blocker, decreased basal 
coronary flow but had no effect on the exercise hyperaemia218. In a 
separate study carried out using the same protocol they infused 8- 
phenyl theophylline, an adenosine receptor inhibitor, and showed 
that although basal flow was reduced (45 vs. 35 ml/min, p<0.05) 
and exercise flow was reduced, there was no reduction in delta flow 
(Exercise-Basal)219. In the same study they then infused both 
glibenclamide and 8-phenyl theophylline and demonstrated no 
further decrease in basal flow but a significant reduction in exercise 
induced hyperaemia (92 vs. 49 ml/min, p<0.05)219. In the final 
study they infused a combination of glibenclamide, 8-phenyl 
theophylline, and L-NMMA (NO inhibitor) and showed that baseline 
flow was reduced (49 vs. 20 ml/min, p<0.05) and that this multiple 
blockade resulted in a complete inhibition (20 vs. 21, 22, 26 +29  
ml/min, baseline and 4 increasing exercise intensities all p=ns) of 
the hyperaemia in response to exercise220.
Effects of m axim al exercise L-nMMa infusion on A rteria l 
Function
The femoral PWV post maximal exercise showed a significant 
reduction throughout the fifteen-minute recovery period during the
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control and L-NMMA study. However, the first ten minutes of 
recovery were significantly different from each other. This 
demonstrates that the immediate increase in arterial distensibility 
post maximal exercise is at least partly mediated by NO synthesis. 
It also demonstrates that NO plays no role in the more prolonged 
reduction in PWV and therefore other factors must play a prominent 
role. The first of these findings suggests that NO almost certainly 
plays a significant role during exercise as well, due to the closeness 
to peak exercise, which would be a logical conclusion. The second 
finding, which is much more surprising, suggests a role for another 
metabolite, a change in sympathetic or parasympathetic tone or 
some unknown mechanism.
Haemodynamic Effects o f L-nMMa infusion a t Rest
Basal inhibition of Nitric Oxide with L-NMMA results in a significant 
increase in blood pressure, systemic vascular resistance and aortic 
pulse wave velocity. However, the heart rate and stroke volume 
drop significantly following L-NMMA infusion (60-54 and 93-86 HR 
and SV respectively), a mechanism that effectively blunts the blood 
pressure rise by approximately 28% (Fig 5.7). There appear to be 
two potential mechanisms, which could account for the reduction in 
heart rate and stroke volume. The first, and more obvious 
explanation is a baroreceptor-induced response to the initial 
increase in mean blood pressure. As we discussed in chapter one,
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an increase in mean blood pressure causes an increase in the firing 
rate of the arterial baroreceptors. Two of the responses to this 
increased rate of firing are a reduction in sympathetic activity and a 
concurrent increase in parasympathetic activity, both of which 
would reduce the heart rate and stroke volume. Recent data 
suggest that the reduction in heart rate when blood pressure is 
increased by L-NMMA is less than blood pressure is similarly 
increased by Phenylephrine because of inhibition of brainstem Nitric 
Oxide221.
The second potential mechanism is that L-NMMA itself will reduce 
NO availability not only in the arterial tree, but also in the 
ventricles. It has been demonstrated that NO is important for 
maintenance of both diastolic volume and ventricular ejection. 
Harrison et al assessed the effects of inhibition of NO with L-N(G)- 
methylarginine hydrochloride (LNMH) on cardiac function in dogs. 
These findings show that at doses of L-NMH and Phenylephrine 
which produce equivalent increases in afterload (Arterial elastance) 
LNMH caused a much lower increase in left ventricular end diastolic 
dimensions (Preload), consistent with previous studies reporting a 
lusitropic effect of NO222,223. L-NMMA also caused a rightward shift 
of the end-systolic pressure relationship that is consistent with a 
negative inotropic response224. This data suggests a preload
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dependent impairment of cardiac output following infusion of L- 
NMMA.
Haemodynamic Effects o f L-nMMa infusion during Sub- 
Maximal Exercise
As exercise began both the systolic and diastolic pressures were 
higher with L-NMMA when compared to baseline. However, analysis 
using the post infusion values as baseline demonstrated a non­
significant rise in SBP (P=0.13) and DBP (P=0.20). It  therefore 
appears that during exercise the impact of inhibition of NO 
synthesis on haemodynamic variables progressively diminishes.
Fig 5.7 Estimated Changes in Mean Blood Pressure w hen  
Cardiac Output is unaffected by NO inhibition
Q *  R = MBP 
Baseline L-NMMA
5.6 (L/min) *  16.5 (mmHg/L) = 89 (mmHg)
Post Infusion L-NMMA
4.6 (L/min) *  21.4 (mmHg/L) = 94 (mmHg)
Post Infusion L-NMMA if we substitute baseline cardiac output into
equation
5.6 (L/min) *  21.4 (mmHg/L) = 120 (mmHg)
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Conclusion
Exercise of a maximal nature improves arterial distensibility in the 
exercising limb, but has no beneficial effects on the aorta as 
assessed by pulse wave velocity. Inhibition of Nitric Oxide synthesis 
with L-nMMa resulted in an increase in arterial stiffness and blood 
pressure at rest but there were no additional effects during 
exercise. The immediate post exercise arterial distensibility is 
influenced by Nitric Oxide but the sustained reduction >10 minutes 
is due to other factors. No measure of aerobic performance was 
influenced by L-nMMa infusion.
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Chapter Six
Vascular Responses to  Acute Sym pathetic Activation
The Role o f N itric Oxide
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Introduction
Central aortic blood pressure (BP) reflects left ventricular afterload, 
and is a key determinant of myocardial oxygen consumption and 
coronary perfusion pressure. Aortic BP may be analysed according 
to both its static and pulsatile components. The static component, 
estimated by mean arterial pressure, is accurately described as a 
function of cardiac output and total peripheral resistance (TPR)225. 
The pulsatile component, estimated by pulse pressure, is affected 
by the patterns of left ventricular ejection, large artery stiffness and 
arterial pulse wave reflection226. Therefore, it is clear that for a 
given cardiac performance, the entire vascular tree influences aortic 
BP.
Chronic mental stress is increasingly recognised as a novel risk 
factor for coronary artery disease227, left ventricular dysfunction228, 
and sudden cardiac death229. Furthermore, there is a clustering of 
cardiovascular events following stresses such as earthquakes or 
bereavement229"231. The mechanistic link between stress and 
increased cardiovascular risk however, remains controversial. The 
haemodynamic response to acute mental stress (AMS), which is 
partly mediated by sympathetic nervous system activation, includes 
increased heart rate, cardiac output and BP. AMS also induces 
endothelial dysfunction232 that persists for approximately 2 hours 
after the stressor. Endothelial dysfunction following mental stress
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may be mediated via increased oxidative stress, or through the 
release of potent vasoconstrictors, such as endothelin233, 234 and 
angiotensin I I 235. Cortisol may also be involved in provoking these 
changes236, 237. It  is suggested that prolonged impairment of 
endothelial-dependent relaxation resulting from AMS, may 
represent an important link between repeated or chronic stress and 
the acceleration of the atherogenic process232.
The responses of various vascular beds to AMS have been studied 
independently in a number of studies and have suggested 
differential responses of the vasculature to AMS. Through this 
approach AMS has been shown to elicit vasodilation in the 
resistance beds of the forearm, but not the calf238"241. To our 
knowledge, the only previous study looking at large artery function 
and AMS has shown an increase in aortic stiffness and pulse wave 
reflections242. Given the important role that vascular dysfunction 
plays in the development of risk factors for cardiovascular disease, 
it is perhaps surprising that concurrent measurement of central and 
peripheral vascular responses to AMS has not yet been reported. 
Furthermore, the vascular and haemodynamic patterns underlying 
the BP response to mental stress are not yet completely 
understood, and in particular the role of endothelial dysfunction in 
modulating these changes is unknown.
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Despite years of investigation, the precise mechanisms through 
which AMS may lead to vasodilation in some vascular beds are not 
yet clear. Previous studies have suggested that sympathetic 
withdrawal240, beta-adrenergic vasodilation240"243 and in particular 
flow-induced nitric oxide (NO) release244, 245 may be of prime 
importance. Vascular NO, known to be a key regulator of basal 
vascular tone, significantly contributes to circulatory modulation 
during various physiological stimuli, including forearm exercise 
hyperaemia246. Although local NO release has been shown to 
contribute to the forearm dilator response to mental stress 
(approximately two thirds of the response was blunted with NO 
synthase blockade)247, its role in the responses of other vasculature 
to AMS is yet to be determined.
This study was split into two sections with all 14 subjects 
completing study 1 and 10 of the initial 14 subjects completing 
study 2. Study 1 assessed the haemodynamic and arterial 
responses to acute sympathetic activation (Mental Stress) while 
study 2 assessed the impact of Nitric Oxide on these responses.
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Methods
Subject Recruitm ent
A total of 14 subjects (9 male) aged 27 ±  1.3 yr (mean ±  standard 
error of the mean, SEM) volunteered to participate in this study. 
None smoked, were hypertensive (blood pressure <140/80mmHg), 
or were taking medication. All subjects gave informed written 
consent and were habituated with the experimental procedures, 
which were approved by the local ethics committee and conformed 
to the Declaration of Helsinki (2002). Subjects were asked to 
refrain from consuming food and caffeine in the eight hours 
preceding the experiments.
Measurements
Stroke volume (SV), beat-to-beat BP and HR were measured using 
the Task Force® Monitor. Continuous beat-to-beat BP was 
assessed using the Flying V cuffs of the Task Force® Monitor at the 
middle finger of the left hand. Central Aortic pressure waveforms 
were derived for, Augmentation Index (A I), end systolic pressure 
(ESP), and the timing of the reflected wave (TR), from radial 
applanation tonometry using the Sphygmocor System. FTPWV was 
measured simultaneously and non-invasively using the SciMed.
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Calculations
Total peripheral resistance (TPR), an index of the static component 
of arterial load was calculated as mean arterial pressure (DBP + 1/3 
PP) divided by CO. Arterial compliance an index of the pulsatile 
component of arterial load is calculated as the stroke volume 
divided by the pulse pressure. Effective arterial elastance (AE), an 
index of arterial load, which incorporates both static and pulsatile 
components, was calculated as central end-systolic pressure 
(obtained from the central pressure waveform), divided by SV.
Study 1 -  Haem odynam ic and A rteria l responses to  Acute  
Mental Stress (N = 1 4 )
Subjects entered the laboratory and were prepared for all 
measurements while in the supine position. During each phase of 
the study we measured pulse wave analysis, cardiac output, heart 
rate, blood pressure, and femoral pulse wave velocity (FPWV). Each 
trial began with a 15-minute acclimation period followed by 10 
minutes of baseline measurements, 6 minutes of acute mental 
stress (Arithmetic Stress Test as detailed in the methodology) and 
10 minutes of recovery readings.
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Study 2 -  The In fluence o f N itric Oxide on these Responses 
(N = 1 0 )
This was a randomised, double blind, placebo controlled, crossover 
study that was similar to study 1. Prior to each trial in study 2, a 
14-gauge Venflon was inserted into a forearm vein of the left arm. 
A bolus infusion of either the nitric oxide synthase blocker NG- 
monomethyl-L-arginine (L-NMMA) (3mg/kg) mixed with 20ml 
saline, or a saline only solution, was infused over a 5-minute period. 
This was followed by a further 50ml infusion of saline with 3 
mg/kg/hour L-LNMMA, or saline only, infused over the remaining 
study period. Each trial began with a 10-minute acclimation period 
and 10 minutes of baseline measurements, this was followed by a 5 
minutes infusion period and 10 minutes of post infusion 
measurements, acute mental stress (6 minutes) and 10 minutes of 
recovery readings.
Statistical Analysis
All values are expressed as mean ± SEM. For study 1, data was 
analysed as the mean baseline and stress measurement periods. 
For study 2, data is expressed as mean of baseline post infusion, 
stress and recovery for both saline and L-NMMA infusion protocols. 
Statistical analysis was performed using repeated measures ANOVA 
and post hoc analysis using paired t-tests with Bonferroni 
correction. Significance levels were set at P<0.05.
161
Results
Subject Data
Table 6.1 Subject Data
Male Age
(Y ears)
SBP
(m m H g)
DBP
(m m H g)
W t
(kg )
H t (m )
Study 1 9 27 121 75 72 1.74
(n=14) (1.3) (3) (3) (2.6) (-03)
Study 2 7 26 120 77 74 1.76
(N=10) ..... ..........(?}. ....( 2 ) ....... (2.1) (-02)
Study 1
Haemodynamic Responses to  Acute Mental Stress
Table 6.2 shows averaged haemodynamic data for baseline and 
stress periods. AMS increased HR, SBP, DBP, MAP and CO (p<0.05  
for all). AMS also caused significant increases in central SBP and 
central DBP (p<0.05 for both).
Table 6.2 Haem odynam ic responses to  AMS
Baseline AMS Rec Base AMS Rec
HR 67±4 82±4* 65±4 CO 6.3±0 .5 7 .7 ±0 .5 * 6 .2±0 .4
(bpm) (l/min)
SBP 121±3 133±4* 125±4 cSBP 106±4 116±3 * 109±3
(mmHg) (mmHg)
DBP 75±3 86±3 * 77±2 cDBP 76±5 87±7  * 78±5
(mmHg) (mmHg)
SV (ml) 95±6 95±8 97±4 ESP 96±3 105±4* 98±4
(mmHg)
HR, heart rate; SBP, systolic blood pressure; DBP, diastolic blood pressure; MAP, 
mean arterial pressure; SV, stroke volume; CO, cardiac output; cSBP, central 
systolic blood pressure; cDBP, central diastolic blood pressure; ESP, end-systolic 
pressure; *  indicates significantly different from respective baseline value.
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As shown in figures 6.1 and 6.2 it is also clear that AMS increased 
AI@HR75, AE, and FTPWV and caused a significant decrease in TPR, 
and TR (p<0.05 for all).
Study 2 
Haemodynamic Response to  Mental Stress w ith  and w ith o u t 
L-NMMA
L-NMMA infusion significantly increased central and peripheral BP's, 
whilst decreasing both HR and SV and therefore CO (all p<0.05). 
The magnitude of the responses to AMS was not different during 
infusion of saline versus infusion of L-NMMA. That is, the absolute 
change from post-infusion to AMS was statistically indistinguishable 
with either vehicle (Table 6.3)
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Figure 6.1 Effects of Sym pathetic Activation on arteria l load
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Figure 6.2 Effects of Sym pathetic Activation on arterial
stiffness
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Table 6 .3  Haem odynam ic responses to  AMS follow ing saline  
or L-NMMA infusion
Baseline______ Post Infusion_________ AMS_________ Recovery
Saline L-
NMMA
Saline L-NMMA Saline L-
NMMA
Saline L-
NMMA
HR 55 ± 2 61 ± 2 56 ± 3 52 ± 2 73 ± 4 66 ± 3 54 ± 3 54 ± 2
(bpm) t * * * * * +
SBP 120± 117 ± 118 ± 3 124 ± 3* 127 ± 2 133 ± 121 ± 128 ±
(mmHg) 2 2 * * 3 * * t 3 4* 4 t
DBP 77 ± 2 70 ± 3 76 ± 2 80 ± 2 84 ± 2 88 ± 3 76 ± 2 83 ±5
(mmHg) * * * * * *
SV 97 ± 2 101 ± 98 ± 3 94 ± 5 98 ± 5 96 ± 6 98 ± 3 95 ± 2
(ml) 6 *
CO 5.3 ± 6.1 ± 5.4 ± 5 ± 0.3* 7.1 ± 6.4 ± 5.3 ± 4.6 ±
(l/m in) 0.2 0.3 + 0.3 0.5 * * 0.5 * 0.2 0.4 *
cSBP 105 ± 99 ± 2 104 ± 3 110 ± 3* t 112 ± 2 118 ± 106 ± 116 ±
(mmHg) 2 * * 2 * * t 2 4* * +
cDBP 77 ± 1 72 ± 3 76 ± 2 81 ± 3 85 ± 2 88 ± 2 76 ± 3 83 ± 4
(mmHg) * * * * *
ESP 95 ± 1 88 ± 3 96 ± 2 100 ± 3 * 103 ± 2 106 ± 98 ± 1 101 ±
(mmHg) * * 2 * * 2
FBF 33 ± 5 38 ± 8 28 ± 4 33 ± 9 * 48 ± 9 * 51± 9
(m l/l/m i * *
")
HR, heart rate; SBP, systolic blood pressure; DBP, diastolic blood pressure; SV, stroke volume; CO, 
cardiac output; cSBP, central systolic blood pressure; cDBP, central diastolic blood pressure; ESP, 
end-systolic pressure; *  Indicates significantly different from respective baseline value, t  Indicates 
significant difference between Saline and L-NMMA values for any given time point, *  Indicates 
significant difference from respective post infusion value
At rest NO synthase blockade reduced TR, whilst inducing increases 
in AI@HR75, AE, FTPWV and TPR (p<0.05 for all) (Figures 6.3 and 
6.4). During both saline and L-NMMA infusion, AMS increased 
AI@HR75, AE, and FTPWV, whilst decreasing TPR and TR (p<0.05  
for all) (Figures 6.3 and 6.4). Although resting baseline (post 
infusion) values were different, the magnitudes of the responses to 
AMS were not significantly different with infusion of saline versus 
infusion of L-NMMA (Figure 6.5).
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Figure 6.3 Effects of Sympathetic Activation on arteria l load 
with Saline and L-nMMa
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Figure 6.4 Effects of Sym pathetic Activation on arterial
stiffness w ith  Saline and L-nMMa
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Figure 6.5 Magnitude of Change w ith  Saline and L-nMMa
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Discussion
This study simultaneously investigated the effects of AMS on central 
and peripheral vascular behaviour, and in a further subset of 
subjects, examined the role of nitric oxide in the vascular responses 
to AMS. The main findings are that (1) AMS causes peripheral 
vasodilation but central arterial stiffening; and (2) systemic NO 
blockade has no effect on the magnitude of these responses. These 
results indicate that the AMS induced pressor response is primarily 
due to large artery stiffening and increased wave reflection and that 
reduction in NO bioactivity does not appear to contribute 
significantly to these changes.
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Haem odynam ic and Vascular Responses to  Acute M ental 
Stress
The haemodynamic responses in this study were similar to that 
found by others242,248, and briefly comprised of a HR driven increase 
in CO, and significant increases in peripheral and aortic BP. Previous 
research has suggested differential responses of the vasculature 
during acute mental stress. A host of studies have demonstrated a 
vasodilator response to mental stress in the forearm238"241, whist 
recently AMS has been shown to result in a prolonged increase in 
aortic stiffness with premature wave reflections242. We aimed to 
further investigate these findings by simultaneously measuring 
systemic and local indices of central and peripheral vascular 
function.
In accordance with a wealth of literature, we have shown increased 
FBF with AMS. Mental stress also decreased TPR, further confirming 
the expected vasodilatation of the resistance vasculature. At the 
same time, AMS increased FTPWV and AI@HR75, and reduced the 
timing of the reflected wave (TR) indicating increased conduit and 
central arterial stiffness. These results clearly demonstrate 
differential responses of central and peripheral vasculature during 
AMS. Arterial elastance (AE), a measure of systemic arterial load 
that incorporates both peripheral resistance and arterial compliance, 
also increased with AMS. This was seen despite decreased
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peripheral resistance suggesting that in the face of peripheral 
vasodilation, increased conduit and central artery stiffening increase 
the arterial load. Our results suggest that both the static and 
pulsatile components of aortic BP are altered with AMS, and we can 
conclude that arterial stiffening and the resulting premature return 
of the reflected waves from the periphery override decreased 
peripheral resistance to cause the observed increased aortic BP with 
AMS.
The Role o f N itric Oxide
NO is known to be a key regulator of vascular tone244, 245, and has 
been shown in two studies, to significantly contribute to the forearm 
vasodilator response to AMS, via cholinergic stimulation of the 
vascular endothelium247,249.
In our study population of healthy subjects, despite the 
vasoconstrictor response to L-NMMA at rest, the haemodynamic 
response pattern to AMS was essentially unchanged during NO 
synthesis inhibition. This data is in accordance with Lindqvist et al. 
2004250. Additionally the systemic (TPR) and local (FBF) 
vasodilatory response to AMS was not attenuated by L-NMMA 
infusion, in contrast to the studies of Dietz et al. and Cardillo et 
a |247, 249 The different influences of local247,249 and systemic250 NO 
synthesis inhibition on forearm vascular responses to AMS highlight
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the importance of reflexogenic regulation of skeletal muscle blood 
flow in the control of arterial BP during stress. It must also be 
noted that FBF was only measured in 5 subjects. It  appears that 
the forearm vasodilatory response may reflect the interaction 
between a host of redundant mechanisms. Although the precise 
contributions of each mechanism are not yet known and are often 
controversial, previous studies have suggested that sympathetic 
withdrawal240 and circulating adrenaline248,251 may also be of prime 
importance. The fact that AMS increases large artery stiffness 
even when NO synthesis is blocked indicates that endothelial 
dysfunction is not responsible, or at most contributes only 
modestly.
To our knowledge, this is the first study to comprehensively 
investigate the role of NO in the vascular responses (other than 
forearm) to AMS. Our results suggest that impaired NO synthesis 
plays little or no part in the overall vascular response to AMS. 
Although NO significantly increased TPR, and both central and 
peripheral arterial stiffness at rest, and therefore is a key regulator 
of basal vascular tone, the responses of these indices to AMS were 
unchanged with NO synthase blockade. We therefore conclude that 
NO plays little role in the vascular responses to AMS and suggest 
that other mechanisms (see below) underlie the adverse effects of 
AMS on vascular function.
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Potential Mechanisms
The increases in heart rate and arterial pressure induced by AMS 
are mediated in part by sympathetic neural activation233 and 
substantial catecholamine (i.e. adrenaline and noradrenaline) 
release252. Circulating catecholamines are widely considered to 
cause vasoconstriction253. Indeed, noradrenaline infusion has been 
shown to result in increases in peripheral and central pulse pressure 
and an increase in augmentation index and aortic stiffness254. 
However circulating adrenaline in concentrations that can be 
produced by mental stress has been shown to cause /J-adrenergic 
stimulation and a regional vasodilatory effect in the forearm248, 251,
253
The heterogeneous distribution of a-adrenoreceptors throughout the 
human vasculature may provide insight into the mechanisms 
underlying the differential vascular response to AMS. It  has been 
demonstrated that large upstream arteries contain a predominance 
of a 1-receptors for the control of arterial BP255, whilst the arterioles 
contain a2-receptors for the fine control of tissue perfusion256, 257. 
Recent studies have also demonstrated that the interaction between 
sympathetic nerve activity and local vasodilatory stimuli appears to 
vary with vessel branch order258. Alpha 2-mediated vasoconstriction 
in the arterioles appears more sensitive to metabolic inhibition than
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al-mediated vasoconstriction further upstream where sympathetic 
nerve activity seems able to impair ascending vasodilation255,256,259, 
26°. Results from the present study may be in accordance with this 
concept, where local dilation in the forearm is able to override a2- 
mediated constriction, but a 1-vasoconstriction upstream in the 
conduit and large arteries is maintained during AMS.
Clinical Im plications
These findings may have important clinical implications. Chronic 
stress is increasingly recognised as a risk factor for coronary artery 
disease, left ventricular dysfunction, and sudden cardiac death227'229, 
and there is also a clustering of cardiovascular events after acute 
stressful episodes231,261.
AMS can act as a trigger for acute cardiac events in susceptible 
individuals, with a vulnerable period of a few hours231,261. Indeed it 
has been reported that relative risk of acute MI was more than 
doubled in the 2 hours following an acute episode of anger or 
severe work stress230,262. Although the pathophysiological basis for 
these effects is not completely known, the onset of acute coronary 
syndrome is thought to involve the disruption of vulnerable plaques 
by rupture or erosion263. It  is suggested that heightened platelet 
activation and increased haemodynamic shear stress may play a 
key role in this process264, and that some individuals may be
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particularly susceptible to the acute onset of acute coronary 
syndrome with AMS due to an impairment (heightened response) in 
these mechanisms265.
From a practical perspective this study highlights the importance of 
adequate rest before assessment of large artery function and as 
such in situations such as open access risk factor clinics and clinical 
trials it is essential to allow a minimum of a fifteen-minute baseline 
period to allow for the effects of stress on the large arteries.
Conclusions
Acute mental stress results in a vasodilation of the peripheral 
vasculature. However, the observed stiffening of the conduit and 
central arteries may provide a mechanistic link between mental 
stress and increased risk factors for cardiovascular disease. 
Although others have shown that NO contributes to the forearm 
vasodilatory response to AMS, our results suggest its role in the 
responses of other vasculature appears to be of less importance.
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Chapter Seven
Conclusions
Exercise M odality and A rteria l Function
Although this study only looked at conduit artery function following 
exercise, it demonstrated that all healthy subjects who undertook 
exercise of a strenuous nature showed an increase in arterial 
distensibility in the early post exercise period. The magnitude of 
improvement was influenced by modality (Aerobic, resistance or 
isometric), duration (2-45 minutes) and intensity (25-100%  of 
V o 2max). It  also demonstrated that the response to resistance and 
isometric exercise resulted in changes in only the arterial bed of the 
exercising limb, suggesting a local control mechanism. In contrast 
the maximal cycle test resulted in brachial and femoral changes in 
P W V , this however may have been due to the increasing use of the 
upper body musculature as exercise intensity increases. This was 
the first study to look at multiple beds in a large group of subjects 
during differing exercise modalities, intensities and durations.
The prevalence o f an Exaggerated Systolic Blood Pressure 
Response to  Exercise in Health and th e  Im p a c t o f 
Cardiovascular Risk Factors
Previous research had shown a significantly independent prognostic 
value of ExSBP, but had failed to ascertain whether ExSBP occurs in 
subjects without risk factors. From 723 visitors to an open access
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risk factor clinic we recruited 100 subjects who had no 
cardiovascular risk factors and demonstrated that no subject had an 
ExSBP and that all subjects without an ExSBP augmented their limb 
conduit artery distensibility and substantial proportion of post 
maximal exercise. The second part of this study demonstrated that 
subjects (45% ) with borderline resting blood pressure and/or mild 
hypercholesterolemia developed an ExSBP, which was still present 
when exercise intensity (I.E. fitness) was accounted for. The 
subjects with ExSBP failed to augment there femoral distensibility 
immediately post and presumably during sub-maximal exercise, 
while the subjects with similar risk factors but a normal response 
had normal augmentation on the femoral distensibility. 
Interestingly there were no significant differences in baseline 
haemodynamics or arterial function between the NSBP and ExSBP 
groups.
The im pact o f m axim al exercise on central (A o rtic ) a rte ria l 
function
Unlike the fall in peripheral arterial stiffness, central arterial 
compliance fell in healthy subjects during exercise. However when 
the rise in blood pressure was accounted for there was no 
significant difference from baseline. Infusion of L-nMMa did not 
alter maximal exercise capacity or any other performance related 
marker but did increase basal blood pressure and arterial stiffness.
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L-nMMA had no additional effects during exercise on blood pressure 
or heart rate but was influential in the post exercise arterial 
response.
The im pact o f acute m enta l stress on haemodynamics and 
arteria l function
Acute sympathetic activation, mental stress, results in central and 
conduit arterial stiffening and may provide a link between stress 
and cardiovascular disease. Although Nitric Oxide influences resting 
arterial function and haemodynamics it appears to have any 
additional effect during stress.
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Chapter Nine
Appendices
Table 9 .1  Definition o f term ino logy
Term s Short Definition
Arterial
Compliance
C The change in compliance of a vessel 
regardless of changes in blood pressure
Arterial
Distensibility
Nil The change in compliance of a vessel 
accounting for changes in blood pressure
Arterial Elastance Ae A measure of total arterial load 
influenced by arterial compliance and 
total peripheral resistance
Total Peripheral 
Resistance
TPR The "stiffness" of the peripheral 
vasculature
Augmentation
Index
Ai A measure of the influence of wave 
reflection on aortic blood pressure
Timing of the 
Reflected Wave
Tr The timing of the arrival of the reflected 
peripheral pressure wave onto the aortic 
waveform
Aortic Pulse Wave 
Velocity
AoPWV The speed in m/s of the waveform 
between the Carotid and femoral artery
Bracho-Radial 
Pulse Wave 
Velocity
BRPWV The speed in m/s of the waveform 
between the upper and lower leg
Femoral-Tibial 
Pulse Wave 
Velocity
FTPWV The speed in m/s of the waveform 
between the upper and lower arm
Exaggerated 
Systolic Blood 
pressure
ExSBP Subjects whom on exercise developed a 
significantly higher systolic blood 
pressure
Normal Systolic 
Blood pressure 
Responders
NSBP Subjects whom on exercise developed a 
normal systolic blood pressure.
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